Unspecified mental disorder

F5_UNSMENDIS

Cestode Infections: Infections with true tapeworms of the helminth subclass CESTODA.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_MENTALUNSPE F5_KELAMENT	21701
6. Filter based on genotype QC (FinnGen only)	21701

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_UNSMENDIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_MENTALUNSPE\|F5_KELAMENT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unspecified mental disorder based on the number of shared cases.

Similar with more cases:

Psychiatric diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21701	12191	9510
Unadjusted period prevalence (%)	4.17	4.16	4.19
Median age at first event (years)	34.68	34.78	34.55

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20241: Matched controls
202184

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

805.3

323.3

318

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

1317.7

323.0

1004

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

91.6

323.0

378

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

1916.4

323.0

873

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

+∞

323.0

410

P01

ICPC

Feeling anxious/nervous/tense

3.2

323.0

3404

12092

N06AG02

ATC

moclobemide; oral

5.8

323.0

1637

3046

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

323.0

3091

13278

F25

ICD-10 Finland

Schizoaffective disorders

3702.9

323.0

374

N05AA01

ATC

chlorpromazine; systemic, rectal

172.0

323.0

1890

121

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.9

323.0

765

890

N06AX05

ATC

trazodone; oral

6.8

323.0

1068

1635

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.2

323.0

3228

8683

F29

ICD-10 Finland

Unspecified nonorganic psychosis

126.4

323.0

6372

732

N03AF01

ATC

carbamazepine; oral, rectal

4.4

323.0

1506

3661

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

940.6

323.0

1883

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

323.0

18029

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

323.0

4281

22409

T36

ICD-10 Finland

Poisoning by systemic antibiotics

13.0

323.0

3341

3019

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.9

323.0

2077

3273

A28

ICPC

Limited function/disability NOS

2.7

323.0

2628

10426

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.6

323.0

3685

9320

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

8.2

323.0

3856

5630

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5045.8

323.0

503

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

17.5

323.0

1970

1240

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

14.9

323.0

1690

1232

29530

ICD-8 Finland

Schizophrenia, Paranoid type

792.9

323.0

390

F99

ICD-10 Finland

Mental disorder, not otherwise specified

199.9

323.0

3401

204

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

82.6

323.0

1421

185

SPAT1243

SPAT

Psychiatric/psychological examination

6.6

323.0

1384

2223

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

12.5

323.0

1498

1289

A10BA02

ATC

metformin; oral

2.3

323.0

5269

26684

N03AE01

ATC

clonazepam; systemic

6.3

323.0

2398

4236

N05AH02

ATC

clozapine; systemic

1783.1

323.0

3513

N05AA02

ATC

levomepromazine; systemic

44.7

323.0

4913

1440

N03AG01

ATC

valproic acid; systemic, rectal

23.4

323.0

5847

3456

P72

ICPC

Schizophrenia

566.0

323.0

2928

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

765.9

323.0

377

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

75.6

323.0

451

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

2614.5

323.0

786

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

903.4

323.0

443

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

1017.7

323.0

400

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

56.7

323.0

2463

493

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

2316.3

323.0

473

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

49.0

323.0

409

P03

ICPC

Feeling depressed

2.9

323.0

2659

10135

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.2

323.0

1208

1137

F20.5

ICD-10 Finland

Residual schizophrenia

1230.9

323.0

714

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

13.4

323.0

2637

2234

P99

ICPC

Psychological disorders other

23.4

323.0

2696

1320

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

1865.4

323.0

386

N05AB03

ATC

perphenazine; systemic, rectal

67.2

323.0

4796

930

C07AA05

ATC

propranolol; systemic

2.7

323.0

5178

22604

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

8.1

323.0

1730

2292

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

18.0

323.0

1495

891

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.3

323.0

4223

9590

P98

ICPC

Psychosis NOS/other

184.0

323.0

932

N06AX12

ATC

bupropion; oral

4.7

323.0

2585

6098

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.3

323.0

1277

1458

N05AE03

ATC

sertindole; oral

1595.6

323.0

456

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

67.8

323.0

1932

314

29599

ICD-8 Finland

Schizophrenia, Unspecified type

1613.7

323.0

610

P28

ICPC

Limited function/disability (P)

26.9

323.0

708

272

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

4637.9

323.0

464

N06AX03

ATC

mianserin; oral

7.5

323.0

2096

3049

N05BA02

ATC

chlordiazepoxide; systemic

7.1

323.0

939

1374

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

41.9

323.0

528

129

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

217.7

323.0

364

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

20.7

323.0

1039

528

IGY99

NOMESCO Finland

Other psychiatric treatment contact

17.1

323.0

1306

811

N05AF03

ATC

chlorprothixene; systemic

59.9

323.0

3599

728

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

66.3

323.0

681

106

N05BA01

ATC

diazepam; systemic, rectal

6.2

323.0

5659

11841

N05AX12

ATC

aripiprazole; systemic

116.6

323.0

6566

829

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

1909.3

323.0

1037

N05CD07

ATC

temazepam; oral

7.7

323.0

5208

8710

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

1204.5

323.0

1352

N06AA04

ATC

clomipramine; systemic

9.7

323.0

802

859

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

1754.3

323.0

968

P29

ICPC

Psychological sympt/compl other

9.2

323.0

3590

4652

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.9

323.0

2863

5509

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

218.5

323.0

1136

N05BE01

ATC

buspirone; oral

11.4

323.0

1732

1642

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

74.7

323.0

1828

268

N05AD03

ATC

melperone; systemic

16.2

323.0

764

487

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2120.2

323.0

2392

SPAT1254

SPAT

Administration of medicine

2.7

323.0

3397

13951

N05AE04

ATC

ziprasidone; systemic

231.7

323.0

972

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

19.6

323.0

740

391

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.0

323.0

1656

4398

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

10.7

323.0

826

803

F31.8

ICD-10 Finland

Other bipolar affective disorders

26.8

323.0

1879

769

N05AL01

ATC

sulpiride; systemic

20.2

323.0

1111

581

N06AB05

ATC

paroxetine; oral

5.1

323.0

2474

5361

F39

ICD-10 Finland

Unspecified mood [affective] disorder

10.5

323.0

1068

F28

ICD-10 Finland

Other nonorganic psychotic disorders

148.3

323.0

450

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.3

323.0

5109

25904

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

+∞

323.0

374

F20

ICD-10 Finland

Schizophrenia

3224.9

323.0

955

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

16.0

323.0

2051

1415

EBA00

NOMESCO Finland

Extraction of tooth

2.2

323.0

7590

43905

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

778.3

323.0

383

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

112.1

323.0

1184

112

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

24.9

323.0

514

211

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

16.9

323.0

661

404

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

54.2

323.0

2688

570

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

22.5

323.0

1302

615

N06AA12

ATC

doxepin; systemic

5.6

323.0

1873

3587

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

83.1

323.0

487

IGY02

NOMESCO Finland

Psychiatric monitoring contact

18.9

323.0

1735

997

N06AX11

ATC

mirtazapine; oral

3.4

323.0

9074

38799

N05BA06

ATC

lorazepam; systemic, sublingual

18.4

323.0

3752

2475

N05AN01

ATC

lithium; oral

94.7

323.0

3628

464

N06AB06

ATC

sertraline; oral

6.4

323.0

5308

10668

N05CF01

ATC

zopiclone; oral

3.4

323.0

8458

35491

F22.0

ICD-10 Finland

Delusional disorder

73.5

323.0

1684

249

188

Kela drug reimbursment

Psychosis requiring demanding treatment

16384.0

323.0

1656

N05AC02

ATC

thioridazine; oral

46.7

323.0

2414

585

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

16.9

323.0

1184

740

F32.9

ICD-10 Finland

Depressive episode, unspecified

5.6

323.0

5727

13199

P76

ICPC

Depressive disorder

4.3

323.0

2364

6082

N05BA12

ATC

alprazolam; oral

3.8

323.0

3181

9524

IGV01

NOMESCO Finland

Psychiatric network contact

44.8

323.0

711

164

N04AA02

ATC

biperiden; systemic

139.4

323.0

2762

229

F20.10

ICD-10 Finland

Raise schizophrenia continuously

646.7

323.0

568

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

30.3

323.0

852

293

IGY02

SPAT

30.4

323.0

589

199

N07BB01

ATC

disulfiram; oral

7.2

323.0

2258

3461

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

8.3

323.0

2714

3689

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.6

323.0

2457

7464

SPAT1234

SPAT

Support of social functional capacity

6.7

323.0

1836

2975

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

21.8

323.0

1583

784

SPAT1240

SPAT

Therapeutic discussion

4.5

323.0

4474

11963

N05AX13

ATC

paliperidone; systemic

8227.9

323.0

802

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

238.6

323.0

1318

F21

ICD-10 Finland

Schizotypal disorder

145.6

323.0

852

29999

ICD-8 Finland

Unspecified psychosis

131.5

323.0

438

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

8.7

323.0

798

946

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

3609.8

323.0

365

IEV99

NOMESCO Finland

Other psychiatric network intervention

55.4

323.0

424

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

73.0

323.0

1874

282

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

24.9

323.0

497

204

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

506.1

323.0

350

AA400

NOMESCO Finland

Electroconvulsive therapy

47.6

323.0

886

194

F31

ICD-10 Finland

Bipolar affective disorder

53.4

323.0

1434

288

N03AX09

ATC

lamotrigine; oral

17.4

323.0

4233

3023

F20.0

ICD-10 Finland

Paranoid schizophrenia

1575.7

323.0

1028

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

2487.9

323.0

990

N05AF05

ATC

zuclopenthixol; systemic

456.2

323.0

1491

N06AA09

ATC

amitriptyline; systemic

3.2

323.0

2431

8358

N05AH03

ATC

olanzapine; systemic

90.9

323.0

9561

1970

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

60.7

323.0

989

171

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

27.9

323.0

456

167

F34.1

ICD-10 Finland

Dysthymia

5.0

323.0

1318

2795

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

106.3

323.0

488

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

6.2

323.0

1059

1779

F60.9

ICD-10 Finland

Personality disorder, unspecified

16.6

323.0

1092

691

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

4242.1

323.0

426

SPAT1307

SPAT

Psychosocial counselling and guidance

3.9

323.0

2303

6493

N06AB08

ATC

fluvoxamine; oral

6.7

323.0

1095

1706

N06AB04

ATC

citalopram; systemic

5.8

323.0

8622

22940

IEY01

NOMESCO Finland

Psychoeducation, individual

24.1

323.0

571

243

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

76.5

323.0

529

N06AB03

ATC

fluoxetine; oral

5.6

323.0

5163

11730

N06AX16

ATC

venlafaxine; oral

5.2

323.0

5866

14638

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

322.3

323.0

799

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

1842.4

323.0

681

F61.0

ICD-10 Finland

Mixed personality disorders

16.0

323.0

1347

894

N05AF01

ATC

flupentixol; systemic

16.6

323.0

1012

637

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

19.1

323.0

826

449

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.2

323.0

2645

9166

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

323.0

4199

20266

T90

ICPC

Diabetes non-insulin dependent

2.4

323.0

4306

20708

N05AD01

ATC

haloperidol; systemic

29.8

323.0

2608

999

N05AE05

ATC

lurasidone; oral

206.0

323.0

444

A06AD11

ATC

lactulose; oral

3.4

323.0

3416

11493

N05BA04

ATC

oxazepam; oral

5.6

323.0

9417

27236

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

37.2

323.0

720

200

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

51.3

323.0

3523

826

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

53.6

323.0

564

108

SPAT1301

SPAT

No procedures

1.9

323.0

6313

38225

29580

ICD-8 Finland

Schizophrenia, Other

351.2

323.0

552

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

1215.7

323.0

359

N05AX08

ATC

risperidone; systemic

46.7

323.0

8834

3294

N05AH04

ATC

quetiapine; oral

17.0

323.0

11990

15886

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

920.1

323.0

451

N06AB10

ATC

escitalopram; oral

2.9

323.0

5959

25389

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

323.0

3475

12847

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.1

323.0

2131

7440

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.4

323.0

2456

5004

P74

ICPC

Anxiety disorder/anxiety state

4.4

323.0

1353

3266

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

21.2

323.0

589

286

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1002.6

323.0

3702

P73

ICPC

Affective psychosis

141.7

323.0

619

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.1

323.0

2506

8718

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

20.1

323.0

1060

554

F20.8

ICD-10 Finland

Other schizophrenia

758.4

323.0

519

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1198.9

323.0

3485

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.7

323.0

980

1174

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

27.6

323.0

462

171

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

79.6

323.0

2653

382

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

22.8

323.0

644

291

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

+∞

323.0

326

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

38.0

320.9

414

111

P15

ICPC

Chronic alcohol abuse

5.3

316.8

1028

2015

N06AA06

ATC

trimipramine; systemic

6.1

312.7

906

1548

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

446.9

310.1

310

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

6.0

310.1

910

1580

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

309.9

4763

26660

OAB43

SPAT

0.3

308.3

921

25439

IER01

NOMESCO Finland

Psychoeducation, group

23.4

306.7

449

196

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

74.0

304.0

349

P27

ICPC

Fear of mental disorder

10.6

303.5

612

593

IGP01

NOMESCO Finland

Psychiatric family contact

35.5

298.6

391

112

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

31.7

295.6

398

128

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

2745.9

290.8

281

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.1

289.0

682

869

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.6

288.9

1411

4101

R53

ICD-10 Finland

Malaise and fatigue

2.1

288.4

4156

22565

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

287.9

4387

24360

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

24.9

287.6

413

169

P50

ICPC

Psychological, Medication/prescr/renewal

41.3

285.7

362

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

75.3

284.7

326

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

84.7

281.2

317

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

275.0

6207

39621

K02.1

ICD-10 Finland

Caries of dentine

1.7

271.4

11783

91458

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.4

270.6

858

1633

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

448.1

267.1

267

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

267.1

256

F30.9

ICD-10 Finland

Manic episode, unspecified

50.7

266.9

325

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

10.2

266.9

549

552

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.8

266.0

702

1056

2971A

ICD-9 Finland

Paranoid states, Paranoia

214.2

265.5

275

N06AX21

ATC

duloxetine; oral

2.4

265.2

2461

10857

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.5

263.8

995

2285

SPAT1241

SPAT

Extensive assessment of psychosocial situation

8.0

261.0

618

791

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

8.6

257.5

585

700

30041

ICD-8 Finland

Neuroses, Depressiva

11.1

256.9

505

465

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

56.4

256.0

306

AA1AD

NOMESCO Finland

CT of head and brain

2.0

255.2

4107

23136

P80

ICPC

Personality disorder

21.6

254.7

382

180

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

+∞

253.5

243

F40.1

ICD-10 Finland

Social phobias

4.9

251.4

883

1882

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.0

250.5

592

755

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

78.1

250.2

285

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

41.2

250.2

317

N05AB01

ATC

dixyrazine; systemic

9.9

249.3

521

539

F10.24

ICD-10 Finland

Alcohol depence active use

7.4

248.9

619

854

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

248.6

1296

3954

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

248.2

4833

29142

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

174.7

246.6

259

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

242.6

9671

72288

WX290

NOMESCO Finland

Other blockade of nerve

1.6

237.3

9398

69960

F20.03

ICD-10 Finland

Paranoid schizophrenia periodically with gradual improvement

+∞

236.8

227

SPAT1235

SPAT

Mental health, emotional support

12.9

235.7

431

341

29540

ICD-8 Finland

Acute schizophrenia episode

395.0

235.0

236

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.4

234.8

1231

3767

N05AH05

ATC

asenapine; oral

176.9

233.5

245

ICB03

SPAT

83.2

232.9

263

L17

ICPC

Foot/toe symptom/complaint

1.8

229.2

4539

27406

F61

ICD-10 Finland

Mixed and other personality disorders

19.3

228.1

355

187

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

2123.4

227.2

220

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

227.0

14032

116869

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

18.1

226.7

361

203

N05CD02

ATC

nitrazepam; oral

7.4

226.6

565

782

SPAT1252

SPAT

Overall medication plan or its review

3.1

226.2

1390

4770

30188

ICD-8 Finland

Personality disorders, Alia definita

33.9

225.4

298

F20.6

ICD-10 Finland

Simple schizophrenia

1109.6

225.2

220

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

142.7

224.9

240

F05.9

ICD-10 Finland

Delirium, unspecified

7.5

224.1

555

760

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

14.6

224.0

388

271

N05CF02

ATC

zolpidem; oral

2.0

223.2

3558

19842

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

221.4

10568

81997

N06AX26

ATC

vortioxetine; oral

2.9

221.3

1515

5579

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

53.0

221.1

267

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

1084.1

220.0

215

F60.8

ICD-10 Finland

Other specific personality disorders

12.3

219.7

410

339

F23.20

ICD-10 Finland

Acute schizophrenia-like psychosis without acute stress factor

722.0

218.1

215

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

20.9

216.7

328

159

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

216.7

2419

11605

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

216.5

3923

22896

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.6

215.1

660

1205

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

708.4

214.0

211

N05AX15

ATC

cariprazine; oral

202.8

212.6

221

T82

ICPC

Obesity

3.6

212.2

1029

2955

IHZ07

SPAT

24.3

211.3

305

127

EBA30

NOMESCO Finland

Excision of root of tooth

3.1

210.2

1243

4144

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

73.9

210.1

241

K59.0

ICD-10 Finland

Constipation

3.2

209.8

1175

3771

P19

ICPC

Drug abuse

8.5

209.8

476

568

N05AC01

ATC

periciazine; systemic

22.4

209.5

310

140

X78

ICD-10 Finland

Intentional self-harm by sharp object

13.5

208.5

373

281

P06

ICPC

Sleep disturbance

2.3

207.2

2159

10011

29500

ICD-8 Finland

Schizophrenia, Simple type

512.6

205.0

204

F20.33

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual improvement

+∞

204.4

196

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

33.3

203.4

270

K08.3

ICD-10 Finland

Retained dental root

2.7

202.1

1488

5721

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.4

201.7

1268

26452

RS220

NOMESCO Finland

7.3

201.4

507

711

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

21.5

200.7

301

142

V03AA01

ATC

6.3

200.5

560

908

M01AH05

ATC

etoricoxib; oral

0.6

200.1

6735

89324

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

110.1

199.4

218

SPAT1260

SPAT

Consultation of another employee

1.9

199.2

3378

19181

F60.0

ICD-10 Finland

Paranoid personality disorder

22.6

199.1

294

132

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

13.9

198.2

350

256

D12

ICPC

Constipation

4.3

197.3

772

1831

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

196.8

1543

6150

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

196.8

7475

54130

N05BA05

ATC

potassium clorazepate; oral

11.3

196.2

381

342

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

195.9

10656

84243

A04

ICPC

Weakness/tiredness general

2.1

195.0

2516

12824

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.2

194.3

779

1891

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

956.6

193.9

190

N06AX18

ATC

reboxetine; oral

7.8

192.4

464

610

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

14.6

191.5

331

230

F23.00

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor

129.9

191.5

206

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

13.8

191.1

338

248

C07AB07

ATC

bisoprolol; oral

1.6

189.5

7152

51560

WX110

NOMESCO Finland

Local anesthesy

1.6

188.9

13443

112803

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

188.1

2773

14905

SPAT1244

SPAT

Occupational therapy

9.3

187.1

403

440

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

11.8

187.0

356

307

R41.0

ICD-10 Finland

Disorientation, unspecified

4.6

186.1

678

1497

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

185.6

5754

39339

H03AA01

ATC

levothyroxine sodium; systemic

1.8

185.3

4148

25787

Z03

ICPC

Housing/neighbourhood problem

13.0

185.0

336

262

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

10.0

183.1

379

385

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

181.8

1307

4942

Z08

ICPC

Social welfare problem

7.1

181.5

465

669

SPAT1310

SPAT

Counselling related to known health issue

1.6

181.3

5905

40851

F23.29

ICD-10 Finland

Acute schizophrenia-like psychosis UNS

174.1

181.0

190

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

43.0

180.2

226

RT250

NOMESCO Finland

45.7

179.1

222

-1

NOMESCO Finland

1.6

178.2

6730

48314

R44.0

ICD-10 Finland

Auditory hallucinations

26.0

178.1

252

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

16.8

177.5

290

175

S10

ICPC

Boil/carbuncle

2.8

177.2

1210

4428

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002030) Lymphocytes/100 leukocytes in Blood

11242

83314

1.72

323.31

9.5

5.9

28.5

28.7

0.77

10481

78141

(3019550) Sodium [Moles/volume] in Serum or Plasma

19859

175716

2.53

322.03

20.4

13.5

mmol/l

139.5

139.7

12.51

19522

171156

(3018010) Neutrophils/100 leukocytes in Blood

11101

82141

1.72

319.57

9.3

5.7

57.4

56.8

6.88

10337

77332

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9578

68198

1.72

316.17

2.5

2.2

nmol/l

70.6

1387.6

0.50

8859

62502

(3023368) Bacteria identified in Blood by Culture

6353

40271

1.82

314.31

4.7

4.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

462

647

7.27

311.23

3.1

1.8

umol/l

170.6

130.1

1.26

223

316

(3023103) Potassium [Moles/volume] in Serum or Plasma

19862

176347

2.49

308.91

20.3

13.6

mmol/l

4.0

1.86

19501

171398

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7157

46416

1.81

307.65

2.7

2.1

u/l

344.5

202.2

8.88

6720

43668

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10787

68141

2.16

307.65

5.9

mmol/l

1.2

12.54

9928

62059

(3006504) Eosinophils/100 leukocytes in Blood

11003

79910

1.76

307.65

9.3

5.9

2.5

2.9

82.12

10258

74836

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9576

61414

2.00

307.65

2.2

1.9

pmol/l

95.6

97.2

2.67

5173

32685

(3019309) Folate [Moles/volume] in Red Blood Cells

5696

25277

2.70

307.65

1.9

1.7

nmol/l

1195.8

1166.2

1.59

4516

19321

(1001926) Buprenorphine [Presence] in Urine by Screen method

2711

7360

4.07

307.65

4.0

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3208

15836

2.20

307.65

1.9

1.7

—

(3011288) Drugs identified in Urine by Screen method

2560

6229

4.52

307.65

5.2

2.8

—

(3027008) Opiates [Presence] in Urine

2905

9909

3.23

307.65

4.2

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

8044

48317

2.06

307.65

3.9

3.2

mmol/l

7.3

8.1

27.18

6827

41222

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4292

23702

2.01

307.65

2.0

1.8

—

(3026008) Bacteria identified in Urine by Culture

7103

44642

1.88

307.65

3.6

2.8

—

(42870588) Differential panel, method unspecified - Blood

8521

56480

1.84

307.65

7.3

6.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8762

51413

2.18

307.65

2.7

3.3

mmol/l

2.4

0.54

7805

45351

(3019069) Monocytes/100 leukocytes in Blood

11095

80349

1.78

307.65

9.9

6.1

8.2

8.5

20.09

10377

75697

(3013115) Eosinophils [#/volume] in Blood

12438

88190

1.96

307.65

11.9

5.8

e9/l

0.2

28.32

11051

78222

(3019150) Specific gravity of Urine by Refractometry

6040

35936

1.94

307.65

5.0

3.6

kg/l

1.0

0.40

866

5257

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6381

24655

3.25

307.65

2.6

1.7

1.6

1.4

83.06

5725

22042

(3013650) Neutrophils [#/volume] in Blood by Automated count

13730

97817

2.10

307.65

21.7

8.1

e9/l

4.4

4.0

47.50

12250

85795

(3013826) Glucose [Moles/volume] in Serum or Plasma

12783

95106

1.84

307.65

5.6

4.5

mmol/l

6.7

6.6

5.96

11864

88004

(3000764) Benzodiazepines [Presence] in Urine

2927

9833

3.28

307.65

4.2

1.9

—

(3022096) Basophils/100 leukocytes in Blood

10741

77383

1.77

307.65

9.3

6.0

0.6

0.7

75.09

10020

72509

(3019198) Lymphocytes [#/volume] in Blood

12269

88051

1.90

307.65

9.7

5.7

e9/l

2.0

1.9

12.14

10838

78432

(3006315) Basophils [#/volume] in Blood

12097

85202

1.95

307.65

9.5

5.8

e9/l

0.0

9.18

10543

74493

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5814

31645

2.14

307.65

1.8

1.6

pmol/l

47112349.5

32169232.3

0.83

4986

26706

(3028707) Methadone [Presence] in Urine by Screen method

2397

3437

7.71

307.65

4.2

2.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

3318

1223

31.84

307.65

6.9

3.3

umol/l

385.9

352.1

10.92

2976

1031

(3028300) Cannabinoids [Presence] in Urine

2924

9929

3.25

307.65

4.2

1.9

—

(3001604) Monocytes [#/volume] in Blood

12045

84883

1.94

307.65

9.4

5.7

e9/l

0.6

11.26

10509

74256

(4198724)

945

733

13.43

307.65

2.9

2.2

—

(40758558) Short blood count panel - Blood

6790

41576

1.92

307.65

12.6

6.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

607

1047

5.93

307.65

2.6

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18784

159542

2.32

307.65

6.9

4.4

mu/l

1.9

2.1

3.97

17796

148195

(3024561) Albumin [Mass/volume] in Serum or Plasma

9796

67679

1.81

307.65

4.2

4.9

g/l

35.8

36.1

8.33

9054

62992

(3044889) 12 lead EKG panel

14598

114541

1.84

307.65

4.4

3.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10363

56635

2.59

307.65

4.0

3.1

u/l

31.3

33.2

0.63

9734

53884

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17189

134009

2.36

307.65

5.5

3.8

pmol/l

14.5

14.6

9.97

16098

123207

(3027944) Amphetamines [Presence] in Urine

2812

9785

3.15

307.65

4.1

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8265

51212

1.99

307.65

2.9

2.6

u/l

51.8

57.9

20.85

7574

47446

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

16729

127493

2.36

307.65

7.2

7.3

u/l

77.4

76.1

3.38

15883

120268

(3018418) pH of Serum or Plasma

7799

44487

2.17

307.65

3.7

4.1

7.4

0.33

1471

8557

(3016879) Cocaine [Presence] in Urine

2863

9115

3.47

307.65

4.2

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11819

75549

2.24

307.65

6.5

6.6

mmol/l

1.2

15.91

9899

63945

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

2231

253

98.15

307.65

13.3

6.5

mmol/l

0.6

0.5

11.76

2065

229

(3021960) Folate [Moles/volume] in Serum or Plasma

6222

32999

2.24

307.65

1.6

1.5

nmol/l

19.1

20.4

9.92

5639

28611

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11584

84024

1.81

307.65

5.2

6.0

umol/l

9.1

11.2

81.05

10836

79575

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3269

15930

2.24

307.65

1.9

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1195

3550

3.50

307.65

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1898

7757

2.58

296.43

2.0

1.6

mu/l

572.3

274.7

33.13

1655

7038

(21494755) Public health laboratory ask at order entry panel

714

24570

0.27

293.45

1.2

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15257

124658

1.75

293.07

4.8

2.9

u/l

47.0

44.8

2.66

14410

117928

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

18869

165236

2.09

284.31

6.0

4.0

mmol/l

6.1

5.8

146.15

17765

152967

(3031040) Bacteria [#/volume] in Urine by Automated count

13585

109551

1.64

252.92

5.6

4.0

e6/l

1654.8

1448.2

0.19

310

1388

(3042517) Benzodiazepines panel - Urine

251

209

12.14

250.78

2.9

2.8

—

(3021589) Normoblasts [#/volume] in Blood

10047

75463

1.62

248.56

12.4

8.9

e9/l

0.0

0.64

8200

62158

(3002032) Base excess in Venous blood by calculation

2569

13101

2.09

236.28

3.8

4.1

mmol/l

2.2

1.8

6.23

2079

10716

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2568

13159

2.08

232.97

3.7

4.0

kpa

6.0

5.8

6.51

2471

12769

(3020191) Ethanol [Moles/volume] in Serum or Plasma

607

1444

4.29

229.51

1.7

1.5

promille

1.1

1.5

10.68

447

1101

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

661

20914

0.29

227.94

1.5

1.7

—

(3026782) Osmolality of Urine

4791

30264

1.75

227.31

2.9

2.7

mosm/kgh2o

503.0

552.3

37.32

4078

25817

(3012544) pH of Venous blood

2600

13623

2.03

221.23

3.7

4.0

7.4

0.37

(3020682) Albumin/Creatinine [Ratio] in Urine

6517

45040

1.64

218.88

4.0

4.1

mg/mmol

8.9

9.4

0.25

4019

29057

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17695

155123

1.76

217.66

7.0

5.0

mmol/mol

39.6

39.0

12.01

16640

145322

(3024354) Oxygen [Partial pressure] in Venous blood

2161

10631

2.15

217.43

3.3

kpa

4.8

4.7

2.75

2068

10268

(3003396) Base excess in Arterial blood by calculation

2950

16361

1.93

212.44

7.2

7.6

mmol/l

1.8

0.9

23.98

2322

12788

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1860

8805

2.22

205.70

7.7

7.1

mmol/l

25.3

24.5

13.93

1746

8190

(3016502) Oxygen saturation in Arterial blood

2667

14536

1.95

201.52

7.4

8.1

94.8

95.9

15.61

2575

13985

(3012516) Albumin [Mass/volume] in Urine

6189

42934

1.62

201.20

3.2

3.3

mg/l

443.3

415.4

0.16

3819

27548

(3027801) Oxygen [Partial pressure] in Arterial blood

2909

16359

1.90

199.93

7.2

7.6

kpa

11.1

12.9

63.27

2771

15620

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2909

16367

1.90

199.61

7.2

7.6

kpa

5.3

5.1

23.43

2767

15637

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5714

38936

1.63

199.45

2.3

2.2

mg/l

2.8

2.9

0.11

4933

33476

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1844

8859

2.18

196.20

1.7

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4217

26670

1.72

195.24

2.6

3.0

mmol/l

2.4

0.62

3598

23275

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2476

13542

1.93

184.10

7.7

8.5

g/l

124.1

122.6

3.03

2378

13049

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6045

42435

1.59

183.61

1.7

1.6

mmol/l

1.7

1.4

69.03

5212

36210

(3019060) Gas panel - Arterial blood

1835

9134

2.10

177.45

5.4

4.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1100

4410

2.57

176.35

1.7

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

856

3051

2.88

172.60

2.2

3.0

umol/l

32.5

34.2

0.69

733

2622

(3037467) Urinalysis macro (dipstick) panel - Urine

13847

116889

1.51

172.02

5.0

4.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3231

19582

1.76

171.73

4.6

6.3

mmol/l

1.0

1.02

2978

18386

(3017509) Phencyclidine [Presence] in Urine

199

209

9.60

169.56

3.1

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

6588

47836

1.54

169.46

3.4

3.1

e6/l

65.1

79.2

0.47

5122

36309

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3881

24988

1.67

164.70

2.8

3.5

mmol/l

0.8

4.58

3556

23439

(3004119) Hemoglobin [Mass/volume] in Venous blood

1691

8510

2.07

158.11

3.3

3.5

g/l

130.8

130.7

0.08

1653

8324

(3014111) Lactate [Moles/volume] in Serum or Plasma

2307

12962

1.87

156.45

6.2

7.4

mmol/l

1.4

1.3

3.13

2191

12517

(3008295) Osmolality of Serum or Plasma

499

1359

3.73

156.28

1.6

1.5

mosm/kgh2o

284.8

279.9

3.58

368

1082

(3000850) Epithelial cells [#/volume] in Urine

4781

32881

1.58

153.79

2.7

2.5

e6/l

7.9

5.6

11.01

4189

28712

(3029937) Albumin [Presence] in Urine by Test strip

6112

44402

1.52

153.59

4.8

3.7

estimate

0.0

6.27

1975

15507

(3018095) Leukocytes [#/volume] in Urine

7542

57250

1.49

153.03

4.0

3.5

e6/l

107.0

79.8

1.22

5458

39508

(1761868) Lipid panel - Serum or Plasma

5077

69674

0.65

152.83

3.3

2.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7621

58309

1.47

146.98

4.1

3.2

ng/l

37.7

64.0

1.52

5080

35063

(3014576) Chloride [Moles/volume] in Serum or Plasma

3002

18570

1.72

146.30

6.8

7.4

mmol/l

103.9

104.5

9.13

2881

18197

(3030467) Casts [#/volume] in Urine by Automated count

5978

43666

1.51

144.59

3.3

3.0

e6/l

0.4

0.73

4569

32381

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

466

14130

0.32

143.52

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

434

1149

3.83

141.57

2.0

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1361

6597

2.13

140.02

3.6

3.5

mmol/l

25.6

25.2

4.84

1321

6394

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1337

6456

2.14

138.88

3.0

0.7

0.01

1268

6213

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2109

12179

1.81

129.57

3.6

3.7

mmol/l

1.2

3.12

1833

10701

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1261

6114

2.13

129.38

4.4

3.9

53.3

49.0

7.27

1246

6046

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

679

2495

2.78

128.99

2.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

10205

83784

1.41

128.25

4.4

3.3

estimate

0.0

0.00

1972

15596

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2552

15669

1.71

126.42

1.9

2.2

nmol/l

387.8

371.4

2.74

2336

14436

(36304419) Bacteria [Presence] in Urine

5796

43089

1.47

124.71

3.2

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1541

8166

1.95

123.55

1.8

1.6

—

(3000991) Gas panel - Venous blood

2105

12345

1.78

122.42

7.3

8.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

846

3580

2.42

120.17

3.4

2.9

mmol/l

25.4

24.5

5.84

778

3115

(3011397) Hemoglobin [Presence] in Urine by Test strip

5223

38279

1.48

119.99

4.2

3.4

—

(3009261) Glucose [Presence] in Urine by Test strip

10245

84797

1.39

119.40

4.4

3.4

estimate

0.0

0.10

1985

15568

(3013707) Erythrocyte sedimentation rate by Westergren method

14388

126181

1.42

118.68

3.8

3.9

mm/h

11.6

10.7

10.96

13296

117784

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

296

682

4.39

116.55

1.4

mu/l

802.0

468.0

3.30

272

653

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

299

698

4.33

115.76

1.5

1.4

74.7

72.3

2.36

275

669

(3021601) Nitrite [Presence] in Urine by Test strip

10139

84043

1.39

115.69

5.8

4.5

estimate

0.0

0.12

2047

16059

(3002385) Erythrocyte distribution width [Ratio]

16624

150025

1.46

114.38

27.9

14.4

13.7

13.6

23.65

16315

146956

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

337

870

3.92

113.92

2.0

1.6

iu/ml

2716491.1

2046606.4

0.38

(40760892) CBC W Ordered Manual Differential panel - Blood

5413

40284

1.46

113.85

7.7

4.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

1039

4940

2.16

111.80

4.4

4.2

mmol/l

1.4

0.63

1020

4867

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1288

23490

0.52

111.52

1.4

—

(3020891) Body temperature

1139

5676

2.06

108.25

5.7

4.9

—

(3017181) Myelocytes/100 leukocytes in Blood

2226

13714

1.69

107.81

5.9

4.1

0.8

0.9

0.56

649

3626

(3003181) Sodium [Moles/volume] in Urine

588

2203

2.71

107.50

1.4

mmol/l

54.1

64.9

7.92

426

1739

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1874

11108

1.75

104.22

2.5

3.5

pmol/l

4.4

4.5

10.85

1564

9987

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1303

7026

1.91

98.55

3.9

4.4

mmol/l

24.5

24.1

2.72

1105

6347

(3028626) Oxygen [Partial pressure] in Capillary blood

717

3085

2.37

97.95

2.9

2.8

kpa

8.3

8.4

0.43

688

2855

(3047181) Lactate [Moles/volume] in Blood

961

4677

2.10

97.13

6.7

5.7

mmol/l

1.4

1.3

1.36

852

4110

(3001019) Free T4 and TSH panel - Serum or Plasma

458

11686

0.38

96.46

1.5

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2819

18920

1.56

95.63

2.4

2.8

umol/l

6.0

8.0

10.15

2212

16427

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2394

15464

1.62

95.61

2.6

u/l

31.2

44.3

2.84

2024

13333

(3043409) Potassium [Moles/volume] in Arterial blood

898

4287

2.14

95.42

4.7

4.4

mmol/l

3.8

3.9

0.36

819

4042

(1616796) Gas panel - Central venous blood

749

3333

2.29

94.63

3.9

3.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1564

9047

1.78

94.27

3.5

3.2

kpa

5.3

5.1

11.60

1478

8368

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1109

5753

1.98

93.95

5.7

5.1

2.0

1.7

8.46

1036

5377

(3021901) Oxygen saturation in Capillary blood

620

2553

2.47

93.33

2.8

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1092

5663

1.98

92.57

5.8

5.1

0.9

0.85

1021

5296

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

155

247

6.31

92.47

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1496

8589

1.80

92.42

3.4

3.2

mmol/l

2.2

1.6

7.71

1131

6263

(3007853) Bacteria identified in Skin by Aerobe culture

2897

19716

1.54

92.02

1.8

1.7

—

(3009343) pH of Capillary blood

1535

8928

1.77

90.69

3.5

3.2

7.4

0.14

263

1160

(3032080) INR in Blood by Coagulation assay

7526

61217

1.35

88.62

7.5

7.8

inr

1.1

1.2

17.35

2585

18158

(3002179) Metamyelocytes/100 leukocytes in Blood

1996

12553

1.65

88.38

5.3

3.9

0.6

0.66

397

2689

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1553

9183

1.74

86.48

2.7

2.3

u/l

4995.0

5969.1

0.47

426

3740

(3027945) Reticulocytes/100 erythrocytes in Blood

2365

15666

1.57

84.21

3.0

2.5

1.8

0.83

2060

13963

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7955

65718

1.33

82.68

4.8

3.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

995

5197

1.96

82.47

2.4

2.3

ug/l

634.7

556.2

0.31

917

4834

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3982

29458

1.43

82.25

4.0

3.5

ng/l

223.0

517.8

6.10

2639

20913

(3010421) pH of Blood

817

3991

2.09

81.61

4.5

3.7

7.4

6.28

670

3398

(3021440) Promyelocytes/100 leukocytes in Blood

2036

13121

1.61

81.34

6.3

4.1

0.1

0.75

565

3376

(3020779) Urea [Moles/volume] in Serum or Plasma

2029

13073

1.61

81.12

5.5

8.1

mmol/l

8.3

9.2

8.14

1924

12506

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1363

7930

1.77

80.15

9.3

10.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

16.38

79.55

1.5

1.4

nmol/l

442.4

559.5

0.48

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4963

38366

1.38

78.84

2.7

2.9

ng/l

998.1

1222.8

4.11

4064

32277

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19861

188964

1.60

77.92

12.4

9.4

u/l

28.3

27.5

3.80

19381

183107

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1514

9143

1.70

77.86

8.5

9.6

1.8

1.4

19.05

1507

9086

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1509

9141

1.70

76.68

8.5

9.7

0.7

0.15

1503

9087

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3610

26622

1.43

75.04

2.8

2.6

e6/l

1.4

1.2

1.00

2008

14857

(3040151) Glucose [Moles/volume] in Capillary blood

426

1641

2.63

73.70

13.6

9.2

mmol/l

7.5

7.4

0.03

357

1349

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

18677

175824

1.44

72.99

5.5

4.3

mmol/l

2.7

2.8

77.27

17455

164390

(3006184) Hemoglobin [Mass/volume] in Capillary blood

696

3365

2.10

71.39

2.4

2.1

g/l

132.2

131.8

0.13

592

2399

(3025159) Blasts/100 leukocytes in Blood

1909

12491

1.58

71.04

6.4

4.1

0.0

0.2

2.37

430

2897

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3595

26757

1.41

70.42

2.3

2.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

207

538

3.87

69.45

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18818

177724

1.44

69.13

17.5

12.4

mg/l

22.4

22.5

0.03

15701

138220

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1735

11218

1.59

67.80

1.6

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1478

9190

1.65

67.72

8.8

9.8

92.7

94.1

15.51

1470

9162

(40767503) Oxygen content in Capillary blood by calculation

654

3151

2.11

67.69

3.1

2.4

16.8

0.10

369

1576

(3017143) Hepatitis C virus Ab [Presence] in Serum

3363

24902

1.41

67.53

1.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

2728

19480

1.46

66.74

1.5

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

968

5393

1.83

65.57

2.1

2.0

ug/l

2.3

2.1

0.23

863

4786

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

142

7.00

65.33

1.1

1.3

mg/l

50.1

47.8

0.13

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3348

24925

1.41

64.91

3.0

2.8

e6/l

4.3

2.8

8.65

1756

13226

(3012501) Base excess in Blood by calculation

692

3467

2.03

64.44

4.7

3.7

mmol/l

2.9

2.4

3.43

482

2309

(3013290) Carbon dioxide [Partial pressure] in Blood

692

3469

2.03

64.34

4.7

3.8

kpa

5.2

5.0

10.32

670

3395

(3027315) Oxygen [Partial pressure] in Blood

694

3493

2.02

63.80

4.7

3.8

kpa

8.7

8.8

0.68

672

3418

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2240

15558

1.49

62.86

4.5

3.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

18384

173522

1.39

62.22

5.0

4.0

mmol/l

4.5

4.7

139.90

17261

163267

(3042936) Bacteria identified in Isolate by Culture

3082

22772

1.41

62.15

2.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

517

2359

2.22

61.43

2.4

1.8

mmol/l

1.7

0.03

506

2310

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

732

3823

1.95

60.52

1.2

1.4

e6/l

50.7

31.7

0.40

545

2953

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

730

3829

1.94

59.58

1.2

1.4

e6/l

674.6

2543.7

1.17

584

3115

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3830

29521

1.36

59.46

2.5

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

670

12445

0.52

59.07

1.4

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2091

14511

1.49

58.69

2.2

2.3

g/l

0.2

1.52

1889

13526

(3039000) Anion gap in Blood

641

3233

2.01

58.58

7.6

6.8

mmol/l

10.8

11.3

2.69

584

2896

(3018572) Chloride [Moles/volume] in Blood

641

3234

2.01

58.53

7.6

6.8

mmol/l

105.2

105.1

0.08

584

2897

(3022948) Iron [Moles/volume] in Serum or Plasma

3278

24725

1.38

58.13

2.3

2.5

umol/l

12.7

13.8

12.63

2995

23016

(3016650) Hepatitis A virus Ab [Presence] in Serum

622

3131

2.02

57.15

1.2

1.1

—

(40761535) Cells panel - Urine sediment

1826

12399

1.52

56.89

3.6

3.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

792

4366

1.84

55.43

1.2

1.3

mg/l

490.3

521.3

0.69

748

4174

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2593

18937

1.42

55.34

8.1

6.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1630

10878

1.54

54.98

3.4

4.1

ng/l

83.6

91.1

2.30

1377

9513

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

716

3840

1.89

54.63

1.2

mmol/l

3.9

3.7

3.07

670

3617

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

17669

166484

1.33

54.57

4.4

3.6

mmol/l

1.5

1.3

224.10

16377

155483

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3026

22744

1.38

54.49

2.3

2.5

g/l

2.4

2.63

2706

21137

(3013512) EKG study

5266

43189

1.29

51.54

4.3

3.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

18191

172448

1.34

51.44

4.9

3.9

mmol/l

1.3

1.5

307.65

16980

161730

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

160

431

3.73

51.12

3.4

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

160

431

3.73

51.12

3.4

2.5

—

(3007463) Buprenorphine [Presence] in Urine

8.00

49.75

5.7

8.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

182

555

3.30

48.13

2.9

2.8

umol/l

28.3

28.5

0.07

121

421

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1958

26970

0.70

47.92

2.5

2.7

ug/l

0.6

0.7

11.55

1359

15884

(3052851) Hemolysis interference index of Serum or Plasma

817

4770

1.74

47.08

2.8

3.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1374

9137

1.54

46.88

6.5

7.3

mmol/l

25.4

24.7

7.89

1352

9064

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

17408

164620

1.29

45.80

15.2

11.2

ml/min/173m2

89.0

86.7

32.83

13752

135649

(3039443) Prostate specific Ag panel - Serum or Plasma

3590

0.24

45.47

1.3

1.6

—

(3019977) pH of Arterial blood

217

762

2.87

45.04

3.3

2.4

7.4

1.16

247

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

973

6030

1.64

44.81

1.9

1.8

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

15.02

44.18

1.7

1.3

nmol/l

139.5

126.7

0.16

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4621

37885

1.28

44.16

1.9

1.8

mg/l

1.1

0.07

3457

28328

(40768804) Tissue Pathology biopsy report

5923

69188

0.80

43.17

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8851

78194

1.22

42.82

3.0

2.8

ug/l

103.8

115.9

3.96

8143

73410

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1107

7170

1.57

42.41

1.1

u/ml

1.3

8.0

1.02

103

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4966

41258

1.26

42.20

1.3

u/ml

1.5

1.7

0.34

1291

11706

(3044290) Cell count panel - Cerebral spinal fluid

640

3596

1.80

42.07

1.2

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

1630

11484

1.45

41.72

2.1

2.6

e9/l

73.6

70.8

2.16

1211

8609

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

697

4047

1.75

40.95

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

398

1933

2.08

40.41

2.3

1.7

90.0

90.3

0.40

392

1903

(3024928) Oxygen saturation in Venous blood

567

3125

1.84

39.72

2.5

3.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1798

13074

1.41

38.55

1.2

iu/ml

98.0

146.3

7.28

586

5043

(3044242) Glucose [Moles/volume] in Arterial blood

180

626

2.89

38.11

2.3

2.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

569

3180

1.81

38.09

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

569

3181

1.81

38.05

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

452

8302

0.53

37.97

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

334

1561

2.16

37.52

1.2

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1662

11997

1.42

37.11

2.5

2.3

ug/l

5.9

7.7

3.22

1427

10501

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

549

3083

1.80

36.19

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

215

845

2.56

35.93

1.0

ng/l

44.4

41.4

0.13

156

590

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

214

843

2.55

35.60

1.0

ng/l

760.8

758.5

0.03

155

580

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1193

8158

1.49

35.44

2.9

2.6

e6/l

0.3

0.47

1165

7915

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

213

840

2.55

35.35

1.0

ng/l

238.7

318.9

5.06

159

601

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1767

12995

1.39

35.33

2.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1133

7686

1.50

35.00

9.1

10.0

mmol/l

24.7

24.2

4.93

1011

7228

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

164

570

2.89

34.81

1.3

1.4

pmol/l

13.3

15.1

3.70

133

479

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

335

6561

0.50

34.54

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

338

6575

0.51

34.12

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

335

6531

0.51

34.05

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

338

6570

0.51

34.04

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

324

1559

2.09

33.80

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

374

6982

0.53

33.12

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2665

21077

1.30

32.60

2.4

2.6

21.2

23.5

14.73

2142

18145

(3036180) Methadone [Presence] in Urine

9.51

32.33

3.2

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12312

132044

0.84

31.67

3.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5011

42790

1.22

31.47

2.2

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

141

3693

0.38

31.04

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2934

23646

1.28

30.85

1.9

2.1

29.5

29.7

1.47

2829

22940

(3003740) Influenza virus B Ag [Presence] in Specimen

142

3689

0.38

30.70

1.1

—

(3022621) pH of Urine by Test strip

1439

10479

1.40

30.37

3.8

2.7

—

(3016038) Potassium [Moles/volume] in Urine

205

855

2.41

30.26

1.2

mmol/l

27.6

36.0

7.11

173

729

(40761536) Microorganisms panel - Urine sediment

1913

14595

1.34

30.10

4.4

3.6

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

11.49

29.99

3.2

1.3

umol/l

2384.9

1115.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2121

16455

1.32

29.70

2.2

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

4917

42305

1.21

28.03

4.1

3.8

94.0

92.3

5.19

4735

41190

(3022217) INR in Platelet poor plasma by Coagulation assay

2323

18405

1.29

27.74

16.6

21.2

inr

1.2

1.3

2.60

306

2775

(1761482) Bacteria [#/volume] in Urine by Culture

567

3474

1.65

27.34

5.1

3.7

—

(3008037) Lactate [Moles/volume] in Venous blood

489

2916

1.69

26.18

3.8

2.9

mmol/l

1.6

0.16

484

2853

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

122

4.76

25.84

1.3

1.5

pmol/l

21.7

13.8

0.83

106

(3047352) Trisomy 18 risk [Likelihood] in Fetus

280

5290

0.52

25.79

1.5

—

(4035726)

979

13753

0.70

25.77

1.4

—

(3005033) Fetal Nuchal fold Thickness US

281

5285

0.53

25.51

1.5

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

177

750

2.37

25.31

2.8

2.4

umol/l

53.5

52.2

0.19

146

636

(3043238) Trisomy 21 risk [Likelihood] in Fetus

294

5422

0.54

25.01

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1594

12169

1.33

24.82

7.7

2.3

e9/l

4.3

4.1

1.55

1288

9802

(3004809) Band form neutrophils/100 leukocytes in Blood

418

2425

1.74

24.76

2.7

3.2

1.3

1.5

0.57

303

1901

(4034850)

784

5305

1.50

24.50

12.9

8.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1508

11443

1.34

24.46

2.8

ng/l

130.6

179.4

5.99

1327

10281

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

972

6872

1.43

24.21

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

1028

7345

1.42

24.15

4.1

3.2

—

(3045716) Anion gap in Serum or Plasma

155

635

2.45

23.91

2.4

2.5

mmol/l

8.6

9.3

1.09

102

472

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

309

5537

0.55

23.83

1.7

1.8

—

(3003694) ABO and Rh group [Type] in Blood

4614

52871

0.84

23.70

1.4

1.5

—

(3000492) Spirometry study

1441

18760

0.75

23.31

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

300

1615

1.87

22.84

2.8

2.2

mmol/l

105.0

105.6

1.51

300

1602

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

221

1071

2.07

22.80

1.2

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

300

1616

1.87

22.79

2.8

2.2

mmol/l

4.0

0.01

300

1603

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

521

3277

1.60

22.66

1.9

2.4

nmol/l

1.0

0.8

2.97

424

2770

(40757494) Bilirubin.total [Moles/volume] in Blood

172

759

2.28

22.46

1.8

2.3

umol/l

11.1

28.4

1.83

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.29

22.22

1.6

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

567

3655

1.57

22.21

1.4

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

385

2256

1.72

22.05

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

466

2872

1.64

22.04

1.6

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

153

648

2.37

21.98

2.6

3.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

189

880

2.16

21.67

1.2

1.3

71.8

66.3

0.31

107

(3026389) Candida sp identified in Specimen by Organism specific culture

417

2509

1.67

21.66

1.5

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

548

3529

1.57

21.58

1.5

1.7

—

(4010399)

1504

11617

1.32

21.50

1.4

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

8.24

21.34

1.8

1.5

nmol/l

263.5

335.1

0.21

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

250

4606

0.54

21.24

1.4

1.5

—

(3022313) Gas panel - Capillary blood

903

6451

1.42

21.23

3.7

3.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

365

6055

0.60

21.12

1.4

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

433

2653

1.64

20.98

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

259

1370

1.90

20.86

3.2

2.9

mg/l

29.0

57.6

1.98

187

991

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

278

1505

1.86

20.84

1.4

1.9

nmol/l

19.2

19.3

0.06

253

1423

(36660697) Celiac disease serology panel - Serum

1837

14694

1.27

20.05

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1042

7718

1.37

19.75

2.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

123

496

2.49

19.72

5.2

6.6

mmol/l

26.1

25.0

2.13

117

455

(3048689) Calprotectin [Mass/mass] in Stool

2823

23736

1.22

19.55

2.0

2.5

ug/g

126.2

133.5

0.48

2123

18867

(3033705) Calcium.ionized [Moles/volume] in Venous blood

284

1587

1.80

19.25

2.9

2.2

—

(3017569) Oxygen content in Arterial blood

137

589

2.33

19.09

2.6

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

266

1470

1.82

18.72

1.4

nmol/l

1.6

1.4

1.86

241

1324

(3008116) Ketones [Moles/volume] in Urine by Test strip

346

2.75

18.72

1.5

1.4

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

38.39

18.51

3.6

1.2

nmol/l

70.4

64.0

—

(3023410) Appearance of Cerebral spinal fluid

307

1780

1.73

18.36

1.3

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.84

18.21

1.1

1.2

mmol/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

891

6537

1.38

17.93

1.3

1.4

u/l

9.0

0.01

707

5394

(44790048)

300

1741

1.73

17.89

1.4

1.5

—

(44806118)

300

1741

1.73

17.89

1.4

1.5

—

(44790049)

300

1741

1.73

17.89

1.4

1.5

—

(44790047)

300

1741

1.73

17.89

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

182

3.41

17.70

1.1

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

661

4619

1.44

17.60

1.4

ug/g

289.0

277.6

0.75

385

2606

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1291

10054

1.30

17.34

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

247

1368

1.81

17.30

1.2

1.3

mmol/l

2.1

2.0

0.52

228

1281

(3030905) Polymorphonuclear cells [#/volume] in Blood

525

3529

1.50

17.05

3.9

3.4

e9/l

4.4

4.0

3.04

525

3522

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

708

5132

1.39

15.37

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

315

1933

1.64

15.31

1.4

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

7.34

15.23

2.4

3.0

ug/l

2.2

2.9

0.74

(3014765) Yersinia sp identified in Stool by Organism specific culture

711

5176

1.39

15.05

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

505

2.26

14.94

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

711

5192

1.38

14.78

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

520

3596

1.46

14.70

2.1

2.5

ug/min

96.8

120.2

0.58

286

2259

(3051387) C reactive protein [Mass/volume] in Capillary blood

498

3420

1.47

14.60

4.6

3.1

mg/l

24.5

26.4

0.54

344

2106

(3041096) Erythrocytes [Presence] in Urine by Automated

5266

47620

1.14

14.30

4.1

2.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1323

0.31

14.19

1.2

1.3

g/l

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

170

893

1.91

14.17

1.2

1.3

u/l

263.1

340.5

0.50

156

819

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

164

3017

0.54

14.02

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

309

1932

1.61

13.97

1.1

1.4

—

(4094501)

280

4469

0.62

13.92

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1022

0.22

13.91

1.3

—

(40761511) CBC panel - Blood by Automated count

19078

186617

1.18

13.91

18.8

11.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

944

1.87

13.78

1.1

—

(3002256) Pathology report gross observation

1807

21558

0.82

13.52

1.2

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

294

2.59

13.44

1.3

1.2

mg/l

24.1

66.1

0.55

211

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

122

589

2.08

12.95

2.9

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

687

5125

1.35

12.54

1.2

1.3

titre

100.4

123.8

0.47

475

(3023419) Bacteria identified in Sputum by Culture

278

1742

1.60

12.51

2.0

2.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

460

3208

1.44

12.51

1.5

1.3

u/l

21.4

24.4

1.26

354

2640

(3007164) IgA [Mass/volume] in Serum or Plasma

4007

35875

1.14

12.39

1.4

g/l

2.2

2.3

3.41

2166

22899

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2434

21000

1.18

12.35

1.7

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

314

2034

1.55

12.26

1.4

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

243

1483

1.65

12.18

2.5

3.3

61.0

57.5

1.49

114

987

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

631

4673

1.36

12.09

2.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

631

4685

1.36

11.90

1.2

1.3

—

(3014271) Vancomycin [Susceptibility]

117

577

2.03

11.78

3.0

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

505

3626

1.40

11.70

1.3

1.4

—

(40768800) Prostate Pathology biopsy report

137

2504

0.54

11.55

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

241

2.62

11.46

19.9

5.4

—

(3025941) Bacteria identified in Stool by Culture

1308

10722

1.23

11.44

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3943

43606

0.88

10.91

2.3

2.5

umol/l

3056.2

3580.8

0.44

3287

38527

(44806420)

320

2.35

10.85

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

394

5572

0.70

10.83

1.4

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

279

2.44

10.73

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

611

4594

1.34

10.65

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

311

2078

1.50

10.59

1.3

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1896

16225

1.18

10.56

1.6

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2553

28996

0.86

10.46

1.3

u/ml

9.9

11.2

0.35

841

11855

(40761995) Spermatozoa Progressive [#/volume] in Semen

868

0.28

10.40

2.8

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

867

0.28

10.38

5.7

6.4

—

(3015183) Erythrocyte sedimentation rate

1111

0.36

10.37

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

655

4995

1.32

10.36

1.2

1.3

titre

506.2

946.4

1.63

144

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

186

2.75

10.22

2.4

3.3

umol/l

38.1

41.2

0.51

160

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

926

1.74

10.15

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

297

1986

1.50

10.10

5.6

6.6

mg/l

11.0

11.1

0.06

267

1827

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

108

3.34

10.08

1.1

u/l

9.8

11.4

0.22

108

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

819

6460

1.28

10.05

1.6

1.8

g/l

1.6

1.5

3.76

699

5519

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

729

5666

1.30

10.04

3.8

3.4

mmol/l

24.9

24.8

0.76

690

5241

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1409

0.45

9.80

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3631

40111

0.89

9.71

2.3

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

366

2596

1.42

9.20

1.4

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

16557

169493

0.90

9.20

25.8

12.6

39.4

40.5

34.72

10539

132474

(40757373) Influenza virus identified in Isolate

307

2.25

9.14

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

305

2095

1.46

9.13

1.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

179

2856

0.62

9.06

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

206

3175

0.65

8.92

1.1

u/ml

2.0

4.4

3.94

100

1271

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

142

821

1.73

8.86

1.5

1.6

nmol/l

39.6

6.8

0.43

118

675

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

158

2575

0.61

8.77

1.0

u/ml

0.2

0.6

1.71

551

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

348

2469

1.42

8.76

1.2

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1368

11568

1.19

8.74

2.0

2.5

g/l

66.2

66.9

2.75

1231

10606

(3019225) pH of Specimen

1699

14641

1.17

8.70

4.1

4.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1743

0.53

8.66

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

183

1140

1.61

8.61

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

220

1435

1.54

8.49

1.1

mg/l

291.2

287.1

0.37

198

1299

(3008898) HLA-B27 [Presence]

567

7303

0.77

8.45

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

454

6024

0.75

8.43

1.7

1.6

iu/ml

3.5

5.5

0.19

104

1255

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3815

34815

1.12

8.27

1.8

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

398

2923

1.37

8.19

1.1

iu/ml

27845.5

722.9

0.50

708

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7613

80429

0.92

8.14

4.2

3.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

178

1119

1.60

8.10

1.3

umol/l

5.3

5.4

0.08

165

1031

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

103

557

1.85

8.08

1.1

1.2

12.0

20.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.17

8.05

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

272

3884

0.70

8.02

1.1

u/ml

3.0

5.9

4.61

145

2060

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

261

2.26

7.97

1.2

nmol/l

0.2

0.3

2.09

174

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

109

1900

0.57

7.93

1.3

pmol/l

56.0

135.4

0.93

552

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

217

3216

0.67

7.82

1.3

ug/l

3.4

3.6

0.30

186

2933

(3010726) Horse dander IgE Ab [Units/volume] in Serum

255

3656

0.69

7.71

1.1

u/ml

0.6

2.2

5.24

928

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

569

4442

1.29

7.68

1.6

1.9

iu/l

20.4

6.3

0.39

182

1706

(3023430) Cat dander IgE Ab [Units/volume] in Serum

197

2962

0.66

7.65

1.1

u/ml

4.9

4.8

0.04

101

1247

(3027923) C peptide [Moles/volume] in Serum or Plasma

151

926

1.63

7.63

1.5

1.8

nmol/l

1.4

1.2

1.57

114

740

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

200

2996

0.66

7.62

1.0

1.1

u/ml

2.8

3.0

0.11

1584

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3359

36808

0.90

7.60

3.6

3.7

21.6

21.7

0.11

1266

15499

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

112

634

1.77

7.59

1.2

2.2

ug/l

1.1

1.0

0.26

103

579

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

254

1752

1.45

7.53

1.4

mmol/l

11.3

12.1

0.46

399

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

3.15

7.50

1.6

1.3

mmol/l

25.9

22.0

1.99

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

107

601

1.78

7.46

2.4

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

125

2.80

7.39

2.0

2.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1019

0.44

7.36

1.5

1.8

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

+∞

7.29

1.4

0.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

182

1182

1.54

7.24

2.2

1.9

u/field

3.0

1.9

1.05

544

(1002224) Polysomnography panel

718

8801

0.81

7.06

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

262

3676

0.71

7.04

1.1

u/ml

0.9

1.2

0.54

108

1571

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

318

4298

0.74

6.78

1.2

1.1

u/ml

1.8

1.4

0.19

143

1742

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

515

6519

0.78

6.76

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

144

902

1.60

6.74

1.1

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

232

3294

0.70

6.70

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

462

3578

1.30

6.69

2.5

2.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1315

0.54

6.49

1.3

1.4

nmol/l

20.5

31.6

5.12

1208

(3011648) Oxygen content in Venous blood

184

1233

1.50

6.39

1.7

2.5

11.5

11.2

0.41

184

1233

(3015076) Soybean IgE Ab [Units/volume] in Serum

1201

0.52

6.34

1.0

u/ml

0.3

1.0

0.84

166

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

338

2526

1.34

6.33

1.7

1.9

titre

1600.0

2906.0

1.01

129

(3045414) Leukocytes [Presence] in Urine

883

7399

1.20

6.32

2.1

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1173

10076

1.17

6.30

1.4

1.3

iu/l

22.0

25.8

4.20

927

8695

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

194

1321

1.47

6.23

1.3

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

194

1321

1.47

6.23

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

194

1321

1.47

6.23

1.3

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

288

2109

1.37

6.16

1.3

1.4

pmol/l

424.3

311.8

1.93

224

1625

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

237

1682

1.41

6.11

1.3

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

201

2859

0.70

5.92

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

518

0.31

5.87

1.3

1.1

u/ml

29.2

58.9

2.51

506

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

160

2.38

5.85

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

140

2123

0.66

5.79

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

273

2006

1.37

5.75

1.1

—

21.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

334

1.92

5.72

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

122

1899

0.64

5.71

1.5

1.6

mmol/l

8.0

7.6

0.59

1158

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.23

5.71

1.3

1.7

u/l

0.4

0.1

0.56

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2823

30774

0.90

5.67

1.3

iu/ml

27.6

34.3

1.50

745

9599

(3020717) Zinc [Moles/volume] in Serum or Plasma

137

887

1.55

5.64

1.5

umol/l

23.0

26.1

0.64

129

850

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

278

0.22

5.61

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

204

1436

1.42

5.56

2.6

2.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

710

5906

1.21

5.54

2.1

1.8

—

(40758292) HTLV I+II Ab panel - Serum

334

0.27

5.53

1.2

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

116

727

1.60

5.50

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

318

1.92

5.49

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

397

5046

0.78

5.47

1.2

—

(3011985) Renin [Units/volume] in Plasma

304

2290

1.33

5.47

1.4

1.6

mu/l

51.9

65.0

0.81

264

2061

(3006922) Hepatitis E virus Ab [Presence] in Serum

195

1376

1.42

5.27

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1304

0.59

5.19

1.1

1.0

u/ml

0.5

1.8

1.46

286

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

217

2972

0.73

5.16

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

305

1.90

5.12

1.1

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

445

1.73

5.02

1.3

1.4

umol/l

17.2

16.4

0.69

395

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

474

3827

1.24

4.99

1.9

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1049

9109

1.16

4.97

1.1

titre

267.6

230.5

0.10

232

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

417

1.75

4.96

1.5

1.3

nmol/l

103.9

124.4

0.63

319

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

173

2.20

4.94

2.1

2.6

mmol/l

0.8

1.0

0.26

119

(4281824)

112

1715

0.65

4.93

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

172

1203

1.43

4.91

2.8

3.4

mu/l

36.1

27.8

1.06

151

1135

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

206

2820

0.73

4.90

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1897

17134

1.12

4.89

2.9

4.3

u/l

227.7

239.5

3.31

1756

16248

(40761539) Cells [Type] in Urine sediment by Light microscopy

385

1.77

4.77

1.1

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

230

1699

1.36

4.77

1.5

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

769

6539

1.18

4.76

1.6

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

762

6477

1.18

4.74

2.2

2.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

476

0.36

4.74

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

410

1.73

4.67

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

287

1.88

4.65

2.9

2.2

mmol/l

7.0

7.7

0.57

172

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

760

8892

0.85

4.64

2.4

3.2

u/ml

79.6

45.5

0.40

723

8592

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

578

1.61

4.64

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1364

0.63

4.49

1.9

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

364

2892

1.26

4.46

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

633

1.57

4.41

3.0

3.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

278

2138

1.30

4.41

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

107

1607

0.66

4.34

1.2

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

377

3024

1.25

4.27

2.9

3.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

289

1.84

4.25

1.1

1.4

ng/l

67.7

79.2

0.15

180

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

437

1.67

4.25

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

238

1804

1.32

4.21

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

205

1525

1.35

4.13

1.3

1.9

—

(3020491) Glucose [Moles/volume] in Blood

179

1304

1.38

4.12

2.5

1.7

mmol/l

7.6

6.5

2.98

135

974

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1105

12465

0.88

4.10

2.3

au/ml

26.6

22.1

0.32

838

(3004588) Protein electrophoresis panel - Serum or Plasma

1061

9356

1.14

4.10

1.9

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

5030

52906

0.94

4.10

2.4

2.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

124

850

1.46

4.02

1.9

1.7

u/field

1.7

2.9

1.79

624

(3028717) Thiamine [Mass/volume] in Blood

182

2.03

4.02

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

189

2.01

4.01

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1180

0.63

4.00

1.1

iu/ml

12.1

7.8

0.49

318

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

362

4464

0.81

3.95

1.2

1.3

u/ml

4.7

5.6

0.22

470

(3008757) Leukocyte morphology finding [Identifier] in Blood

212

1599

1.33

3.91

2.8

3.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

180

1328

1.36

3.85

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2895

31000

0.92

3.85

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

370

4538

0.81

3.84

1.2

1.3

u/ml

7.6

8.5

0.13

721

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

301

2385

1.27

3.83

1.2

1.3

nmol/l

0.2

1.07

134

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

620

0.50

3.81

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

698

0.53

3.79

1.8

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

429

1.63

3.77

1.1

—

(3000012) Reticulocyte production index

110

747

1.47

3.77

1.5

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

301

2393

1.26

3.74

1.2

1.3

nmol/l

0.7

1.8

0.98

285

2303

(3042631) Mycobacterium sp identified in Specimen

243

1884

1.29

3.70

2.3

2.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.00

3.68

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

819

0.57

3.67

18.1

27.2

ug/l

115.9

115.5

0.01

673

(1617658) Protocol used for examination of sentinel lymph nodes

1178

0.64

3.66

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

171

1263

1.36

3.66

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

169

1246

1.36

3.66

1.7

1.5

umol/l

68.4

70.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1019

11446

0.88

3.57

1.2

1.3

au/ml

61.3

46.0

0.69

473

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

436

1.61

3.56

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

352

1.68

3.54

1.3

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

241

1.83

3.54

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

890

1.42

3.53

1.4

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

171

1271

1.35

3.53

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

1213

0.66

3.49

2.1

1.9

mg/l

3.5

3.7

0.18

1153

(40768795) Lymph node Pathology biopsy report

113

1604

0.70

3.48

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

221

1.86

3.47

1.0

1.4

47.7

56.3

0.45

111

(3037121) Protein [Mass/volume] in Urine

620

5332

1.17

3.45

2.7

3.2

g/l

0.3

0.64

259

2390

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

766

0.57

3.45

2.0

mg/l

8.4

9.4

0.58

618

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

546

4649

1.18

3.44

2.0

1.9

pmol/l

179.3

202.7

5.60

506

4456

(4038314)

257

0.35

3.40

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

184

2412

0.76

3.40

2.3

2.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

328

1.68

3.33

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

439

1.57

3.25

1.1

—

(4146454)

191

1464

1.31

3.22

2.5

2.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

597

0.54

3.22

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

773

1.42

3.21

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

116

2.16

3.21

1.6

1.8

umol/l

48.2

46.3

0.08

116

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

297

3647

0.81

3.19

1.2

u/ml

2.6

4.4

0.72

276

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1332

14628

0.90

3.15

3.1

4.0

ug/l

23.5

24.3

0.03

1089

11551

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

117

2.14

3.14

1.6

1.2

ml/s/173m2

1.1

1.8

0.55

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.73

3.14

1.1

1.0

pmol/l

152.7

160.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

416

4938

0.84

3.14

1.2

1.3

u/ml

46.3

37.2

0.17

307

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

293

3596

0.81

3.14

1.2

u/ml

37.1

17.0

—

(3045424) Erythrocytes [Presence] in Urine

344

2835

1.22

3.14

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

252

0.36

3.13

2.4

2.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

193

1.87

3.13

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1314

0.69

3.13

1.2

u/ml

54.4

41.0

—

(40762365) Oxygen content in Arterial blood by calculation

230

1.78

3.10

3.5

3.3

ml/dl

14.8

0.04

219

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

245

1.76

3.09

1.1

pmol/l

1.4

4.4

—

(3020393) Adenovirus Ag [Presence] in Stool

152

1.97

3.08

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1129

10187

1.11

3.07

1.3

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

253

1.74

3.06

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

330

0.39

3.05

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

838

0.62

3.05

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

397

3330

1.20

3.03

1.5

nmol/l

0.4

0.75

304

2640

(3001729) Color of Synovial fluid

119

2.10

3.03

1.3

1.5

—

(3007461) Platelets [#/volume] in Blood

20201

200627

1.10

2.97

34.5

17.5

e9/l

257.8

254.3

11.62

19814

195954

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

171

1308

1.31

2.96

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

174

2250

0.77

2.95

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

133

981

1.36

2.95

1.1

nmol/l

0.6

6.3

2.44

195

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

190

1.84

2.95

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

694

0.59

2.95

2.4

2.9

—

(4024509)

180

1393

1.29

2.88

1.8

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

221

1.77

2.87

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

171

1316

1.30

2.85

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

229

1.75

2.85

6.7

5.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

422

1.54

2.85

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

966

0.66

2.81

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

235

1890

1.25

2.75

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1172

0.70

2.72

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

166

1283

1.30

2.70

1.2

1.1

—

(40768793) Breast Pathology biopsy report

295

3552

0.83

2.67

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1280

0.72

2.62

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

124

925

1.34

2.61

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

109

797

1.37

2.60

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

329

1.58

2.58

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1296

0.72

2.55

1.1

1.0

u/ml

0.3

2.1

1.68

324

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.73

2.54

1.0

1.6

—

(3022145) Colonoscopy Study observation

1773

19024

0.93

2.52

1.3

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

337

3986

0.84

2.52

1.4

pmol/l

89.9

120.7

2.26

326

3883

(3043410) Blood group antigens tested for on Red Blood Cells

435

1.50

2.52

2.3

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

205

1644

1.25

2.50

1.1

1.2

mg/l

35.7

41.5

1.62

170

1385

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

194

1546

1.26

2.50

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

109

803

1.36

2.50

1.5

—

(40768797) Stomach Pathology biopsy report

2379

22389

1.07

2.50

1.2

—

(40768443) Skin Pathology biopsy report

641

7222

0.88

2.47

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

334

1.56

2.44

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

287

2391

1.20

2.44

1.2

1.3

u/l

33.8

31.9

0.10

250

2089

(3042733) HLA Ab [Presence] in Serum

682

0.63

2.43

5.7

4.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3810

39828

0.95

2.43

1.7

1.6

—

(3024471) HLA-A [Type]

657

0.62

2.42

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

203

1635

1.24

2.40

1.7

2.0

ug/l

20.3

23.6

0.69

198

1602

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

507

1.44

2.37

1.3

1.7

iu/ml

—

426.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

400

0.52

2.36

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

400

0.52

2.36

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

400

0.52

2.36

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

125

1.92

2.34

1.8

4.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

576

0.61

2.33

2.2

3.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

124

943

1.32

2.33

1.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

484

5527

0.87

2.32

1.7

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

311

2625

1.19

2.31

1.4

—

(3024731) MCV [Entitic volume]

20204

200851

1.08

2.30

34.3

17.4

90.4

90.5

1.27

19955

198418

(3035947) Staphylolysin Ab [Units/volume] in Serum

109

815

1.34

2.30

1.1

iu/ml

5.0

3.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

851

0.68

2.28

1.3

—

(3035941) MCH [Entitic mass]

20201

200827

1.08

2.28

34.3

17.4

30.1

30.2

21.55

19954

198396

(3024932) HLA-DR beta [Type]

646

0.63

2.27

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

204

2500

0.81

2.27

3.6

3.5

u/ml

32.2

35.4

0.23

195

2416

(21494434) Karyotype in Bone marrow

1188

0.73

2.26

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

165

1310

1.26

2.24

1.4

umol/l

12.4

11.7

0.63

125

1258

(3026361) Erythrocytes [#/volume] in Blood

20204

200873

1.08

2.23

34.5

17.5

e12/l

4.6

1.40

19765

195737

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

179

1.73

2.21

3.2

2.3

u/field

0.5

0.7

0.60

179

(3034860) Kappa light chains.free [Mass/volume] in Serum

475

4161

1.14

2.20

2.5

3.2

mg/l

52.8

66.0

0.38

387

3362

(3048879) Bone marrow aspiration report

390

0.54

2.19

1.9

2.2

—

(4027681)

161

1280

1.26

2.17

1.2

1.3

—

(3045788) Cell count panel - Pleural fluid

142

1112

1.28

2.17

1.4

1.5

—

(3022689) Creatine [Moles/volume] in Urine

476

1.43

2.15

1.4

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

179

0.39

2.14

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1251

11571

1.09

2.12

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

136

1065

1.28

2.09

1.3

1.4

mmol/l

6.2

5.5

4.15

126

1009

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

905

0.71

2.09

3.0

mg/l

7.0

8.0

0.53

722

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

461

4050

1.14

2.07

2.4

3.2

ratio

1.3

2.8

2.11

340

(3010813) Leukocytes [#/volume] in Blood

20204

200925

1.08

2.07

34.8

17.5

e9/l

7.1

6.7

186.28

19764

195750

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.90

2.07

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

117

1.88

2.05

1.0

1.5

41.9

33.2

0.38

(3001556) Androgen free Index in Serum or Plasma

277

1.55

2.04

1.6

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

230

1.61

2.03

1.1

1.2

mmol/l

1.9

1.8

0.18

142

(40765096) Chromosome analysis panel by Banding

418

0.57

2.03

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

211

1744

1.21

2.01

1.1

1.2

u/l

57.5

61.7

0.45

146

1180

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

403

0.57

1.99

1.0

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

20204

200953

1.07

1.98

34.7

17.6

g/l

136.2

137.2

16.80

19964

198536

(3013005) Retinol [Moles/volume] in Serum or Plasma

105

801

1.31

1.98

1.6

1.7

umol/l

1.9

2.0

0.29

747

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

471

4159

1.14

1.97

2.5

3.2

mg/l

37.1

45.6

1.11

382

3365

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

683

0.67

1.97

1.0

u/ml

4.5

10.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

698

1.33

1.97

1.4

5.3

mg/l

72.8

2918.7

2.80

499

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

244

0.45

1.96

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

103

1340

0.77

1.96

2.1

2.7

e6/l

854.8

728.4

0.71

550

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

427

3749

1.14

1.96

2.0

2.2

g/l

0.0

1.11

376

3420

(21494815) CD4 cells/100 lymphocytes in Specimen

127

1606

0.79

1.93

2.1

2.2

42.2

—

220

(3035320) C reactive protein [Mass/volume] in Body fluid

154

1239

1.24

1.92

3.3

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

244

2883

0.84

1.90

2.4

3.5

u/ml

144.7

799.3

2.03

217

2642

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

106

1.89

1.90

1.1

1.5

10.3

12.0

0.13

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.00

1.89

1.1

1.4

0.2

0.8

2.10

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

240

0.46

1.89

1.1

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

156

0.38

1.88

1.0

1.1

—

5.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

3.18

1.87

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

230

1933

1.19

1.86

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.65

1.86

1.2

1.1

1.7

3.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

105

810

1.30

1.85

1.2

1.1

u/l

74.3

87.2

1.34

668

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

342

1.46

1.83

2.5

2.7

—

(3034426) Prothrombin time (PT)

695

0.69

1.83

1.3

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

126

997

1.27

1.82

1.3

1.5

u/l

10.1

12.4

4.91

121

965

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

419

3699

1.14

1.80

2.1

2.2

g/l

0.0

0.00

375

3412

(3044941) Cell count panel - Synovial fluid

282

2421

1.17

1.79

1.4

—

(3044007) Cell count panel - Peritoneal fluid

426

0.61

1.77

1.7

2.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

116

1.81

1.77

1.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

156

1270

1.23

1.77

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

104

807

1.29

1.77

1.2

1.1

u/l

17.6

26.4

1.42

646

(3041184) Isoniazid [Presence] in Urine

3.33

1.74

1.7

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

353

4019

0.88

1.71

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

103

1.84

1.71

1.4

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

194

1.60

1.70

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1041

0.76

1.70

1.7

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

104

812

1.28

1.70

1.5

1.6

mmol/24h

3.0

5.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

1.70

0.0

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4493

46396

0.96

1.70

3.7

4.2

ug/l

2.5

2.7

0.17

3973

42170

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

111

1.80

1.68

1.2

1.1

nmol/l

18.3

13.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

527

0.66

1.66

1.9

2.1

e6/l

432.0

3385.0

1.01

356

(3004775) Volume in Urine collected for unspecified duration

141

1146

1.23

1.65

2.0

2.4

730.4

675.9

0.63

824

(40760888) Immunoglobulin light chains.free panel - Serum

359

3159

1.14

1.65

2.5

3.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

191

1600

1.20

1.65

1.0

1.1

mg/l

229.3

256.2

1.50

162

1414

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

152

1843

0.82

1.62

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

181

1.60

1.62

1.1

1.3

mmol/l

1.7

1.8

0.03

120

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

813

0.74

1.59

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

460

0.65

1.57

1.5

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

144

1182

1.22

1.55

1.2

1.3

mmol/l

6.2

6.3

0.13

127

1091

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

691

1.29

1.55

2.1

ug/min

96.0

132.1

0.24

157

(3027974) Hepatitis B virus e Ag [Presence] in Serum

107

1.78

1.54

1.2

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

159

0.44

1.53

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

339

1.42

1.53

1.0

1.1

umol/24h

0.8

0.9

0.22

167

(3051651) Icteric interference index of Serum or Plasma

120

968

1.24

1.53

3.4

3.7

—

(3035880) pH of Pleural fluid

675

1.29

1.53

1.1

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

346

0.61

1.51

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

468

1.35

1.50

1.3

62.3

52.6

1.25

395

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

244

0.53

1.49

1.4

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

545

4948

1.10

1.49

2.0

2.2

g/l

10.1

10.3

0.51

446

4194

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

590

1.31

1.49

1.1

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

100

1253

0.80

1.49

1.9

2.7

e9/l

0.2

1.36

1076

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

103

1286

0.80

1.48

1.9

2.6

e6/l

603.5

523.4

0.94

1073

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

826

0.75

1.48

2.4

2.5

au/ml

229.3

140.5

—

117

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.00

1.48

1.0

1.1

g/l

0.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

602

5496

1.10

1.47

1.1

u/ml

5.0

6.0

0.33

809

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

583

5315

1.10

1.47

1.9

2.2

g/l

3.8

0.29

407

3838

(3032352) Blasts [#/volume] in Cerebral spinal fluid

168

0.48

1.46

1.1

2.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.84

1.45

1.1

u/l

29.3

50.1

1.65

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

845

0.76

1.45

1.1

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

583

5320

1.10

1.44

1.9

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

452

4072

1.11

1.44

2.0

2.2

g/l

0.0

3.57

400

3734

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

102

1.76

1.44

1.1

—

3.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

1118

11915

0.93

1.43

1.3

u/ml

272.4

252.3

0.18

1000

11075

(3025577) Chromium [Mass/volume] in Blood

752

0.74

1.43

2.0

2.1

ug/l

2.1

2.4

0.31

630

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

583

5326

1.10

1.42

1.9

2.2

g/l

7.3

0.13

412

4035

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

239

0.54

1.41

2.3

2.9

pmol/l

64.5

75.7

—

207

(3023199) Leukocytes [#/volume] in Pleural fluid

171

1443

1.19

1.41

1.4

1.5

e6/l

7204.9

2321.1

1.01

120

1050

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

138

1142

1.21

1.40

2.2

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1076

0.79

1.40

5.7

6.9

—

(40768441) Liver Pathology biopsy report

104

1286

0.81

1.39

1.3

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

980

1.23

1.39

1.1

1.3

u/l

17.1

21.1

0.55

104

836

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

333

3743

0.89

1.38

3.7

5.9

iu/ml

294.5

1530.9

1.77

539

(40768446) Kidney Pathology biopsy report

758

0.75

1.37

1.9

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

373

0.64

1.37

1.5

g/l

9.8

13.2

1.17

280

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1017

0.79

1.37

1.4

1.5

ug/l

6.8

7.2

0.13

922

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

335

3761

0.89

1.37

1.2

u/ml

43.6

42.5

0.03

365

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.80

1.36

1.3

1.6

ug/g

231.2

160.9

0.59

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

336

0.62

1.36

1.9

ug/l

1.7

3.0

0.96

200

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

470

5178

0.91

1.36

2.6

3.6

u/ml

877.0

1574.5

0.48

396

4456

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

467

0.68

1.35

2.0

e6/l

3344.5

14577.0

1.40

245

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.67

1.33

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

123

1013

1.22

1.33

1.1

1.3

u/l

79.6

86.6

0.55

110

882

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

244

2131

1.15

1.32

1.3

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

133

1105

1.20

1.32

1.2

1.3

u/l

544.8

370.4

2.92

125

1056

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

115

942

1.22

1.31

1.6

1.5

u/ml

26.9

23.0

0.29

199

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

196

1685

1.16

1.31

3.0

4.9

u/ml

33.8

92.9

4.21

558

(3029634) Reagin Ab [Titer] in Serum by VDRL

341

3045

1.12

1.30

2.0

2.3

titre

5.3

7.6

—

(3036603) Volume of Urine

131

1089

1.20

1.29

1.4

1.7

2237.1

2010.4

0.49

234

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

478

5245

0.91

1.29

2.3

2.5

187.2

182.2

0.57

451

4974

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

174

0.52

1.28

1.1

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.88

1.28

1.0

u/ml

0.0

0.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

378

1.35

1.27

1.3

1.4

3.6

3.1

0.17

321

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

302

1.39

1.26

2.1

2.7

mg/l

38.5

44.7

0.16

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

293

2601

1.13

1.25

1.4

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

269

1.41

1.24

3.8

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

699

7529

0.93

1.24

1.6

1.7

mg/l

4.1

3.5

1.52

572

5136

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

160

1361

1.18

1.24

3.4

3.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

241

0.58

1.23

18.3

1.2

mmol/l

8.0

7.3

—

(3051611) Lipemic interference index of Serum or Plasma

186

1602

1.16

1.23

3.2

3.3

—

(3025130) Human papilloma virus identified in Specimen

309

2757

1.12

1.22

1.5

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.96

1.21

1.1

nmol/l

196.4

257.3

1.34

(3003434) Protein [Mass/volume] in Pleural fluid

188

1623

1.16

1.21

1.4

1.5

g/l

35.4

33.6

1.41

170

1475

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

148

1.55

1.19

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.83

1.19

1.4

1.1

—

(3004451) EKG impression Narrative

639

1.25

1.18

1.2

1.3

—

(4133840)

591

0.74

1.17

1.3

1.2

—

(3036489) Thrombin time

710

6608

1.08

1.16

1.9

2.1

20.3

21.3

4.25

600

5666

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

231

1.43

1.16

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

127

0.47

1.16

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

108

1299

0.83

1.15

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

456

1.29

1.13

1.3

1.4

57.1

61.3

0.42

381

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

171

1477

1.16

1.12

1.5

29.6

32.6

0.46

103

907

(3013945) Hepatitis B virus e Ab [Presence] in Serum

103

1.65

1.12

1.2

1.5

—

(3024263) Appearance of Synovial fluid

100

824

1.21

1.12

1.4

1.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

115

0.43

1.11

4.4

5.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

109

1304

0.83

1.11

1.2

1.3

u/ml

1.6

1.3

0.16

560

(3014891) Appearance of Pleural fluid

151

1.52

1.11

1.5

1.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.70

1.11

1.3

umol/24h

2.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

694

6475

1.07

1.08

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

205

0.58

1.06

1.5

3.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

101

839

1.20

1.06

1.2

1.3

titre

1060.0

437.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

622

1.24

1.05

1.1

1.2

115.4

109.8

1.05

560

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

465

0.73

1.05

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

623

0.77

1.03

1.3

1.8

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.27

1.03

1.2

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.27

1.03

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.63

1.03

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

166

1445

1.15

1.01

1.3

1.4

e6/l

58584.9

99644.8

0.64

110

995

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

542

5028

1.08

1.01

1.9

2.2

g/l

3.1

3.0

0.13

409

3950

(3000285) Sodium [Moles/volume] in Blood

180

1.44

1.00

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

120

1020

1.18

0.99

1.4

1.6

u/l

4.4

5.8

0.45

506

(3000093) Morphology [Interpretation] in Blood Narrative

168

1466

1.15

0.99

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

178

2026

0.88

0.99

1.5

1.6

iu/ml

30.9

32.2

—

105

(3017704) Immunofixation for Urine

693

1.21

0.97

1.2

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.80

0.96

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

116

1.55

0.96

1.7

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

935

0.82

0.95

8.8

6.5

u/ml

3139.5

4024.6

0.08

204

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

198

0.61

0.95

4.4

8.0

umol/l

0.1

0.3

—

185

(3011412) CD3 cells [#/volume] in Blood

152

1740

0.87

0.93

2.0

2.5

e9/l

1.3

1.2

1.24

104

1015

(3007919) Fasciola sp Ab [Titer] in Serum

2.22

0.93

1.2

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

102

864

1.18

0.90

1.2

1.3

u/l

15.5

12.9

0.66

804

(3037756) Immunofixation for Serum or Plasma

300

2729

1.10

0.90

1.3

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

237

2130

1.11

0.90

3.2

3.0

nmol/l

0.8

0.01

183

1584

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

811

1.18

0.88

1.2

1.3

titre

30.0

83.0

—

(4268621)

188

2112

0.89

0.88

2.4

2.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

199

1774

1.12

0.88

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

193

0.62

0.87

1.3

1.4

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

1.3

1.8

0.57

113

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

0.4

1.2

1.65

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

1.9

2.6

0.27

110

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

2.7

1.9

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

3.7

4.6

0.28

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

2.0

2.2

0.07

106

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

0.9

0.01

109

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

1.1

2.3

0.92

114

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

161

1.43

0.86

1.7

1.6

mg/l

2.5

1.7

0.20

103

(3009445) Proteinase 3 Ab [Units/volume] in Serum

752

7106

1.06

0.85

1.4

1.6

u/ml

21.5

12.6

0.56

214

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

106

907

1.17

0.85

1.1

100.3

97.0

0.53

739

(3025468) Yersinia sp identified in Specimen by Organism specific culture

230

2073

1.11

0.84

1.3

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

156

1374

1.14

0.84

2.6

2.8

—

0.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1844

19078

0.96

0.84

4.7

4.0

29.5

31.9

18.31

1353

13550

(3026726) Creatinine [Moles/volume] in Specimen

137

0.58

0.83

1.6

2.6

umol/l

695.5

401.7

—

130

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

230

2076

1.11

0.83

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

230

2078

1.11

0.81

1.3

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

399

1.25

0.81

1.2

1.3

41.8

39.9

0.13

267

(3000060) B lymphocytes [#/volume] in Blood

533

0.79

0.81

1.6

2.1

e6/l

182.6

206.7

0.20

280

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.55

0.81

2.7

3.3

18.8

16.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

148

1305

1.13

0.80

1.4

1.5

e6/l

28660.0

47498.9

1.01

785

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

446

4155

1.07

0.80

2.0

2.1

g/l

37.9

38.2

0.49

384

3602

(3039162) Centromere protein B Ab [Units/volume] in Serum

200

2222

0.90

0.79

1.2

1.3

u/ml

61.8

56.7

—

149

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

285

1.30

0.79

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1406

0.87

0.78

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

191

2124

0.90

0.78

1.2

1.1

97.4

96.3

0.22

177

2002

(3019832) Treponema pallidum Ab [Presence] in Serum

2374

24411

0.97

0.77

1.8

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1403

0.88

0.76

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1403

0.88

0.76

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

910

0.85

0.76

2.0

2.1

u/l

187.3

198.9

1.12

905

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

166

1.39

0.75

1.7

1.6

mg/l

2.0

0.00

111

(36303858) Crystals [Presence] in Urine

2.08

0.74

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

324

0.74

2.8

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

386

4144

0.93

0.73

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.84

0.73

1.0

2.3

mu/l

1.0

2.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

108

1.48

0.73

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

299

2755

1.09

0.73

1.3

1.4

mmol/l

7.9

7.0

3.63

198

2011

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

107

0.56

0.72

4.7

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

915

0.85

0.72

1.1

u/ml

3.2

10.1

4.39

170

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

483

4537

1.07

0.71

2.1

2.3

g/l

0.5

0.8

1.73

411

3948

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1392

0.88

0.70

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

160

1.38

0.70

1.1

1.3

u/l

25.3

304.1

0.85

118

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1391

0.88

0.69

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

743

7797

0.95

0.69

2.1

1.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

276

2992

0.92

0.69

1.9

2.1

umol/l

6.1

6.3

0.07

209

2176

(40759836) Histone Ab [Presence] in Serum by Immunoblot

123

1389

0.88

0.68

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1367

13201

1.04

0.67

2.1

2.6

g/l

10.4

10.6

1.02

1221

12105

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

441

0.79

0.67

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

128

1.41

0.65

1.0

u/ml

0.1

0.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.54

0.65

1.0

u/ml

0.0

0.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

171

1.35

0.65

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.59

0.65

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

103

1.46

0.64

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

338

0.77

0.64

6.2

5.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

440

1.20

0.64

1.2

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

270

0.74

0.64

3.9

5.2

ug/min

52.7

43.0

0.21

202

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

279

3010

0.93

0.63

1.3

1.2

u/ml

3.9

0.01

129

1345

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

262

2833

0.92

0.63

2.2

2.8

u/ml

1100.0

3583.2

0.68

134

(3024869) Neuronal Ab [Presence] in Serum

287

1.25

0.63

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

139

1245

1.12

0.63

2.0

g/24h

1.0

1.2

0.12

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

199

0.70

0.61

1.0

u/ml

0.5

—

102

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.60

0.61

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

316

1.23

0.60

1.1

u/ml

0.0

4.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.60

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

141

0.64

0.60

1.2

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

209

1.29

0.60

1.0

1.3

—

6.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

105

1.43

0.59

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

676

1.15

0.59

1.1

1.2

g/l

0.3

3.00

540

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

125

1119

1.12

0.58

1.0

1.1

u/l

1.1

0.06

497

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

113

0.62

0.58

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

365

0.79

0.57

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

227

2096

1.08

0.57

1.3

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

979

0.88

0.57

1.2

u/ml

3.0

14.7

—

114

(3012989) Citrate [Moles/time] in 24 hour Urine

1.67

0.56

1.0

1.6

mmol/24h

1.8

2.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.57

0.56

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

399

3764

1.06

0.56

1.5

1.6

e6/l

10294.1

13102.4

1.30

275

2755

(3013293) Extractable nuclear Ab [Presence] in Serum

274

0.77

0.55

1.5

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

654

6834

0.96

0.55

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

634

0.85

0.55

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

100

1123

0.89

0.54

1.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

137

1511

0.91

0.54

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

693

1.14

0.53

2.6

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

123

1109

1.11

0.53

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

487

4633

1.05

0.52

3.1

mg/l

1.5

1.4

1.06

442

4310

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

811

0.87

0.51

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

500

0.84

0.51

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

167

1817

0.92

0.51

2.6

3.3

nmol/l

5.8

9.0

0.48

156

1766

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

724

1.13

0.50

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

724

1.13

0.50

1.3

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

225

2092

1.08

0.50

1.3

1.5

—

(3016750) Collection duration of Urine

848

1.12

0.49

1.8

2.3

min

521.2

499.8

1.16

667

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

119

1076

1.11

0.49

2.0

96.4

97.7

0.18

114

988

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.49

0.49

7.5

11.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

455

4776

0.95

0.49

1.9

2.1

mg/l

10.9

0.01

423

4480

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.56

0.48

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

110

1.36

0.48

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

154

1.30

0.48

1.1

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

146

1.30

0.46

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

188

0.74

0.46

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

440

0.84

0.46

1.2

g/l

37.0

39.4

0.52

239

(40768806) Pleura Pathology biopsy report

139

1274

1.09

0.45

1.4

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.59

0.45

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

237

1.22

0.45

10.8

10.2

mmol/l

5.7

5.3

0.27

237

(3049242) von Willebrand panel - Platelet poor plasma

1.40

0.45

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

980

0.90

0.45

1.1

miu/ml

1833.9

1491.1

1.91

980

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

228

1.23

0.45

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

112

1.34

0.44

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

572

1.14

0.44

6.7

11.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

701

6760

1.04

0.44

1.9

1.8

nmol/l

37.9

39.3

0.81

681

6621

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

180

1672

1.08

0.43

1.2

1.3

titre

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

241

0.79

0.43

1.5

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

333

3161

1.05

0.42

1.3

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.65

0.42

1.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

384

4026

0.95

0.42

1.4

u/ml

16.3

21.7

0.61

(3050794) Legionella sp Ab [Presence] in Serum

140

1.29

0.41

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

194

1.24

0.41

1.3

1.4

6.9

11.6

0.59

104

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

316

0.82

0.41

1.3

4.5

u/l

49.2

66.2

—

118

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

388

1.16

0.41

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.36

0.41

1.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.40

0.0

3.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

292

3079

0.95

0.40

1.3

1.2

u/ml

3.2

3.6

0.17

103

1068

(3012494) Peanut IgE Ab [Units/volume] in Serum

549

1.13

0.40

1.1

u/ml

3.7

2.4

0.24

295

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

106

0.66

0.39

2.0

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

215

0.79

0.39

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

192

0.78

0.38

1.0

u/ml

0.3

0.1

—

105

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

373

3899

0.96

0.37

1.2

1.3

u/ml

268.2

263.3

0.14

225

2585

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

101

1102

0.92

0.37

1.6

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

487

4685

1.04

0.37

2.9

3.4

u/ml

0.4

0.3

0.46

291

2634

(3027570) Oxalate [Moles/time] in 24 hour Urine

116

1.29

0.37

1.1

1.4

umol/24h

356.1

329.6

0.21

116

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1049

0.91

0.36

2.8

37.8

39.8

0.37

351

(3002621) Streptococcal DNAse B [Units/volume] in Serum

134

1.27

0.36

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

150

1397

1.07

0.36

1.7

2.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

386

0.85

0.36

2.6

2.5

ng/l

124.5

105.1

0.29

198

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

132

1225

1.08

0.35

1.2

1.1

ratio

1.1

0.62

435

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.66

0.35

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

212

0.80

0.35

1.6

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

129

1389

0.93

0.35

1.9

2.1

74.8

73.8

0.38

123

1336

(3044009) aPTT.lupus sensitive (LA screen)

201

0.80

0.35

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

319

1.16

0.35

1.5

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

691

0.90

0.35

2.0

2.1

—

(3030313) Adrenal Ab [Titer] in Serum

199

1.21

0.34

1.2

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

2458

24948

0.98

0.34

1.3

1.4

titre

445.8

528.5

1.53

388

4874

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

732

0.90

0.34

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

127

1366

0.93

0.34

1.9

2.1

10.9

14.1

3.14

653

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

717

7382

0.97

0.34

1.4

1.3

miu/ml

210.3

226.3

0.47

210

3519

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

324

3098

1.05

0.34

1.4

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.30

0.33

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

552

5702

0.97

0.33

2.0

2.2

95.4

92.8

1.78

498

5291

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

906

0.92

0.32

1.6

1.8

137.8

138.8

0.04

843

(3019174) dRVVT (LA screen)

198

0.81

0.32

1.3

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

192

1.20

0.32

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

101

1.29

0.31

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

112

1040

1.08

0.31

1.2

1.5

u/l

5.4

6.0

1.06

896

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

883

0.92

0.31

1.1

iu/ml

267.3

182.3

1.37

876

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

760

7399

1.03

0.31

1.7

2.1

u/l

38.5

39.4

0.62

673

6697

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.73

0.30

3.6

5.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1354

13279

1.02

0.30

3.0

2.5

ml/min/173m2

70.5

70.3

0.05

529

5013

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

276

2884

0.96

0.30

1.1

121.3

117.5

1.31

248

2631

(37021550) Renin [Units/volume] in Plasma --upright

346

0.87

0.29

1.3

mu/l

34.6

93.7

1.68

256

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

185

0.81

0.29

1.0

u/ml

0.0

0.5

—

107

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

557

5404

1.03

0.29

1.6

1.7

g/l

0.2

0.32

523

5145

(3024891) Influenza virus A+B Ag [Presence] in Specimen

517

5010

1.03

0.29

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

134

1258

1.07

0.29

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1045

10234

1.02

0.28

1.6

1.8

g/l

1.3

0.13

948

9403

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.29

0.28

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

767

1.08

0.27

1.6

1.5

2.4

3.6

0.76

176

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

362

3748

0.97

0.27

1.5

u/ml

103.3

110.1

0.76

814

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

272

2830

0.96

0.26

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

120

1276

0.94

0.26

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

240

2503

0.96

0.26

1.1

g/l

1.5

0.13

209

2277

(3006462) Nitrate [Presence] in Urine

780

0.92

0.26

3.4

3.0

—

(3012565) Volume of 24 hour Urine

818

1.08

0.26

1.7

2.1

2206.4

2017.7

0.50

745

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

626

1.09

0.25

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

487

0.90

0.25

1.0

1.1

—

(44813793)

141

1336

1.06

0.24

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

392

4041

0.97

0.24

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.72

0.24

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

284

1.13

0.23

1.0

ug/l

65.4

81.3

1.95

237

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

304

3144

0.97

0.23

1.2

titre

116.0

175.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

143

1.19

0.23

1.1

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

143

1.19

0.23

1.3

1.1

—

(3007733) Chloride [Moles/volume] in Urine

1.28

0.23

1.0

1.8

mmol/l

95.0

90.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

640

1.08

0.22

1.1

94.7

91.3

0.32

282

(3044927) Protein electrophoresis panel - Urine

121

1276

0.95

0.22

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

721

0.93

0.22

1.7

2.1

13.4

9.4

1.48

676

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3049233) Organic acids panel - Urine

0.00

0.21

0.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

637

0.93

0.21

1.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.4

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

101

0.79

0.21

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

104

0.77

0.21

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

157

1501

1.05

0.21

1.1

1.2

titre

63.3

212.6

6.73

261

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

543

0.92

0.20

12.7

1.3

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3049717) Cytology report of Urine Cyto stain

502

4903

1.02

0.20

2.1

2.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

569

5567

1.02

0.20

1.6

1.7

g/l

1.2

1.92

536

5314

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

1.15

0.19

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

437

0.91

0.19

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

260

1.12

0.19

1.1

u/ml

0.0

0.3

1.63

164

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.15

0.19

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

695

1.06

0.18

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

143

0.84

0.18

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

227

0.88

0.18

1.1

1.0

u/ml

0.4

0.1

0.41

140

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

166

1.14

0.18

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

258

0.89

0.17

1.0

—

(3028433) Virus identified in Specimen by Culture

581

1.07

0.17

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

681

0.94

0.17

1.1

1.5

—

(4062490)

198

1919

1.03

0.15

1.2

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

224

0.89

0.15

1.1

—

(3013762) Body weight Measured

1.15

0.15

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

790

0.95

0.15

1.8

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.12

0.15

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

497

1.07

0.15

1.6

ug/l

10.7

8.6

1.85

497

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

533

0.94

0.14

1.6

2.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.80

0.14

2.9

3.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

229

2351

0.97

0.14

2.6

3.1

u/ml

79.6

743.1

0.92

220

2215

(3005011) Chlamydia sp Ab [Titer] in Serum

264

0.91

0.14

1.8

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

728

7178

1.01

0.14

1.2

u/ml

0.4

0.9

2.47

626

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

133

1377

0.97

0.14

1.4

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

225

2309

0.97

0.14

1.6

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.83

0.13

18.1

9.7

e6/l

113.6

281.5

—

(4015189)

376

0.93

0.13

2.2

2.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

631

0.95

0.12

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

241

0.91

0.12

1.3

—

(3021788) Differential panel - Synovial fluid

284

2898

0.98

0.12

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

681

0.95

0.12

1.1

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

836

1.04

0.11

1.3

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

836

1.04

0.11

1.3

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

836

1.04

0.11

1.3

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

293

2986

0.98

0.11

1.1

—

(3003338) MCHC [Mass/volume]

15820

157963

1.00

0.11

32.2

14.8

g/l

332.2

333.3

43.93

15710

156741

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

193

1976

0.98

0.11

1.5

1.6

52.9

55.9

0.45

118

1250

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

332

0.93

0.11

1.2

1.1

u/ml

1.0

1.6

0.35

231

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

648

0.96

0.10

1.4

2.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

187

1828

1.02

0.10

1.9

2.0

mg/l

29.5

25.2

0.35

471

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.14

0.10

7.0

9.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

164

1.10

0.09

1.0

1.1

umol/24h

2.1

1.7

0.75

164

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

625

0.96

0.09

1.1

99.8

92.4

0.79

282

(3003157) Bacteria [#/volume] in Mother's milk

1.04

0.09

3.8

7.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

694

1.04

0.09

1.0

1.1

ng/l

212.2

386.8

0.43

159

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.11

0.09

1.0

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.11

0.09

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

512

0.96

0.08

1.6

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

439

1.05

0.08

1.6

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

195

1913

1.02

0.08

1.2

1.4

g/l

2.9

3.0

0.21

137

1313

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

328

0.94

0.08

1.3

ug/l

33.7

249.1

1.71

177

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

371

1.05

0.08

1.0

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

195

1915

1.02

0.08

1.2

1.4

g/l

6.5

6.8

0.46

135

1313

(3006270) Folate [Moles/volume] in Blood

136

1330

1.02

0.08

1.1

nmol/l

362.0

380.4

0.47

100

1168

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.84

0.07

1.0

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

520

0.96

0.07

1.4

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

372

1.05

0.07

15.4

7.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

147

1.09

0.07

6.0

3.2

g/mol

43.4

40.9

0.05

131

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.84

0.07

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

837

1.03

0.07

1.3

2.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

812

0.97

0.07

1.5

2.4

ug/l

18.9

187.0

1.32

779

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

640

0.97

0.07

1.4

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

640

0.97

0.07

1.4

2.4

—

(4211845)

852

0.97

0.06

3.2

2.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

103

0.87

0.06

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

254

0.94

0.06

6.7

7.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

374

1.04

0.06

1.2

pmol/l

399.1

318.4

0.35

274

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

243

0.95

0.05

1.1

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

131

0.92

0.05

1.3

1.4

—

14.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

672

1.03

0.05

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

141

0.92

0.05

1.0

1.1

—

2.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

405

1.04

0.05

1.1

85.7

84.6

0.05

118

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

405

1.04

0.05

1.1

70.3

75.1

0.23

114

(3024139) IgG subclass 3 [Mass/volume] in Serum

194

1914

1.01

0.05

1.2

1.4

g/l

0.4

0.14

136

1315

(3024980) IgG subclass 4 [Mass/volume] in Serum

305

3022

1.01

0.04

1.3

1.6

g/l

0.6

0.8

2.16

229

2274

(3016330) Potassium [Moles/time] in 24 hour Urine

268

1.04

0.04

1.3

—

90.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

681

6772

1.01

0.04

1.6

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

342

0.96

0.04

1.4

1.6

ug/l

0.3

0.4

0.98

229

(4306422)

298

3004

0.99

0.04

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1487

14912

1.00

0.04

2.5

2.2

nmol/l

11.2

13.0

14.47

1279

13509

(3008536) Aspergillus sp Ab [Presence] in Serum

300

0.97

0.03

1.3

2.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

168

0.95

0.02

2.5

3.3

mg/l

1.1

1.0

0.11

108

(3004446) Plasmodium sp identified in Blood by Light microscopy

218

0.96

0.02

2.3

2.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

439

0.98

0.02

1.5

1.8

u/l

17.8

36.4

1.57

395

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

278

0.97

0.02

4.5

6.2

60.8

69.2

0.88

216

(44806071)

282

1.03

0.02

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

566

5643

1.00

0.01

1.6

titre

294.7

298.7

0.01

221

(3022475) Manganese [Moles/volume] in Blood

123

1.06

0.01

1.1

1.3

—

(4212803)

123

1.06

0.01

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

532

1.01

0.01

1.3

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

294

1.02

0.00

1.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

417

4162

1.00

0.00

1.3

1.4

—

(3025315) Body weight

155

1.03

0.00

6.3

4.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

658

1.00

0.00

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

332

0.99

0.00

16.3

7.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

531

1.00

0.00

2.1

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

1042

1.00

0.00

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

525

5253

1.00

0.00

2.5

2.7

g/l

3.7

3.6

1.16

497

4995

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

144

0.97

0.00

1.0

u/ml

0.0

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

451

4505

1.00

0.00

1.2

1.5

iu/ml

47.2

12.3

—

103

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

402

0.99

0.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

402

0.99

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

402

0.99

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

402

0.99

0.00

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

143

0.98

0.00

1.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.96

0.00

1.1

10.3

8.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.98

0.00

1.0

1.4

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.96

0.00

1.1

21.7

20.9

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

2.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.96

0.00

1.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

0.95

0.00

1.3

mmol/l

33.3

17.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.91

0.00

1.2

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.89

0.00

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.90

0.00

1.4

1.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.98

0.00

56.5

7.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_UNSMENDIS – Unspecified mental disorder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Unspecified mental disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints